hg_6730.1

Basic information about the TSS

---

TSS ID: hg_6730.1 Species: human Chr: chr1		Start: 173487966 End: 173487983 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AJ844622 Distance: 400 GeneID: 9588 HGNC/MGI_ID: HGNC:16753 UniProt_ID:

Gene_name: peroxiredoxin 6 Gene_symbol: PRDX6 Gene_synonyms: 1-Cys AOP2 KIAA0106 MGC46173 NSGPx PRX aiPLA2 p29 Gene_source: HGNC:16753

TATA-Box annotation

---

Distance to TSS:	10628
Nearest PromoterID:	NM_004905
Entrez ID:	9588
Nearest Unigene:	Hs.120
Nearest Refseq:	NM_004905
Nearest Ensembl:	ENSG00000117592
Gene Name:	peroxiredoxin 6
Gene Alias:	1-Cys
Gene Description:	peroxiredoxin 6
Gene Type:	protein-coding
CpG%:	0
GC%:	0.40796
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PRDX6 p2@PRDX6 p3@PRDX6 p4@PRDX6 p9@PRDX6 p10@PRDX6
Sample		p1@PRDX6	p2@PRDX6	p3@PRDX6	p4@PRDX6	p9@PRDX6	p10@PRDX6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	242.53	44.80	37.01	0.00	0.00	10.32
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	238.94	39.86	37.63	0.00	0.40	8.09
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	253.86	48.03	36.07	0.00	0.19	8.49
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	235.77	44.49	34.51	0.42	0.21	5.61
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	247.69	40.94	31.95	0.45	0.67	5.85
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	245.75	42.83	30.04	0.39	0.00	8.92
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	339.68	52.07	41.62	0.00	0.22	11.55
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	273.47	42.39	40.94	0.00	0.00	10.90
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	275.05	46.59	35.05	0.21	0.00	6.63
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	184.32	22.03	20.29	0.00	0.00	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	181.91	16.57	23.45	1.21	0.00	4.45
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	162.21	18.70	18.29	0.00	0.00	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	367.36	31.11	59.00	0.16	0.16	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	358.28	36.99	50.52	0.00	0.15	9.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	317.91	29.86	50.72	0.00	0.00	9.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	342.03	32.19	49.29	0.00	0.25	9.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	349.23	37.78	55.04	0.00	0.22	9.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	327.75	23.62	48.51	0.42	0.42	7.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	344.42	37.32	50.12	0.00	0.00	9.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	377.01	32.65	54.46	0.15	0.00	8.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	351.64	34.48	52.39	0.40	0.40	10.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	356.12	36.77	55.07	0.00	0.17	8.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	371.61	35.93	47.83	0.26	0.26	8.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	363.27	45.62	55.81	0.49	0.24	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	354.74	33.28	58.31	0.26	0.26	10.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	313.03	39.56	51.27	0.32	0.32	8.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	374.73	35.71	57.14	0.55	0.00	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	410.92	37.96	52.57	0.24	0.00	9.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	340.33	32.63	47.97	0.48	0.32	8.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	388.53	36.92	54.47	0.00	0.36	9.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	404.45	37.68	51.08	0.21	0.63	9.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	366.54	34.19	52.75	0.39	0.20	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	353.47	38.20	44.32	0.42	0.00	12.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	428.68	62.51	61.52	0.16	0.16	12.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	406.89	31.79	54.41	0.37	0.19	10.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	389.76	33.92	51.74	0.00	0.00	12.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	400.18	33.93	53.55	0.41	0.00	9.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	437.83	41.51	57.63	0.60	0.20	11.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	442.43	38.35	57.53	0.27	0.27	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	392.02	31.93	52.33	0.72	0.00	9.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	383.00	42.35	48.23	0.24	0.47	8.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	402.14	40.70	54.75	0.00	0.29	9.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	416.94	32.69	60.10	0.63	0.00	9.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	389.86	33.92	62.06	0.17	0.17	7.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	399.74	36.74	63.24	0.20	0.00	9.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	403.87	33.50	59.32	0.70	0.23	9.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	428.71	29.99	49.66	0.72	0.24	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	395.81	30.70	49.48	0.00	0.60	11.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	432.31	28.49	56.73	1.44	0.48	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	420.37	28.51	48.73	0.00	0.20	10.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	431.02	27.46	66.61	1.23	0.82	7.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	457.87	32.02	72.49	1.11	0.67	7.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	251.86	69.96	55.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	486.51	35.49	92.97	1.42	0.71	9.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	506.36	41.09	76.55	1.33	0.00	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	340.61	122.48	51.18	1.68	0.00	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	367.39	54.19	64.75	0.46	0.46	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	569.46	41.49	104.69	2.27	0.00	8.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	479.19	29.23	83.18	2.57	0.64	9.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	387.57	47.46	70.41	0.31	0.94	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	528.09	33.84	88.13	1.41	0.71	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	497.42	40.94	75.15	0.56	0.00	10.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	253.17	43.79	47.77	0.80	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	353.02	36.69	48.25	0.34	0.34	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	582.26	27.94	76.03	1.62	0.32	9.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	440.53	22.72	65.32	2.48	0.35	9.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	387.93	113.15	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	197.44	86.87	31.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	648.40	37.54	52.65	2.44	0.00	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	660.50	35.70	58.51	4.96	0.50	8.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	573.26	35.65	53.95	2.81	0.94	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	703.78	35.11	52.99	2.32	0.66	10.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	1100.64	37.74	80.43	3.71	1.55	25.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	859.75	23.54	61.15	2.14	1.22	15.29
Adipocyte - breast, donor1	11376-118A8	392.32	50.84	47.20	0.00	0.32	14.25
Adipocyte - breast, donor2	11327-117E4	525.56	36.10	41.71	0.48	0.32	9.30
Adipocyte - omental, donor1	11473-119C6	632.58	60.69	47.58	0.51	0.51	15.52
Adipocyte - omental, donor2	11474-119C7	348.33	53.82	32.14	0.00	0.00	6.73
Adipocyte - omental, donor3	11475-119C8	644.05	64.97	37.85	0.67	0.00	7.70
Adipocyte - perirenal, donor1	11476-119C9	393.00	61.25	48.49	0.64	0.00	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	360.64	23.09	61.57	0.00	0.00	13.19
Adipocyte - subcutaneous, donor2	11336-117F4	480.98	52.39	60.52	0.00	0.45	10.39
Adipocyte - subcutaneous, donor3	11408-118E4	807.54	52.48	102.35	0.35	0.17	10.77
Adipocyte differentiation, day04, donor1	13019-139D4	176.41	30.90	30.12	0.00	0.00	8.41
Adipocyte differentiation, day04, donor2	13022-139D7	127.92	21.36	24.97	0.00	0.00	4.63
Adipocyte differentiation, day04, donor3	13025-139E1	172.00	24.25	28.71	0.56	0.28	6.97
Adipocyte differentiation, day04, donor4	13028-139E4	214.55	31.74	21.16	0.00	0.00	7.05
Adipocyte differentiation, day08, donor1	13020-139D5	421.15	34.83	38.61	0.24	0.40	8.93
Adipocyte differentiation, day08, donor2	13023-139D8	247.88	24.85	27.11	0.00	0.00	7.10
Adipocyte differentiation, day08, donor3	13026-139E2	324.71	23.99	30.92	0.00	0.53	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	432.91	31.72	33.94	0.00	0.56	7.23
Adipocyte differentiation, day12, donor1	13021-139D6	413.40	20.79	44.92	0.00	0.42	6.24
Adipocyte differentiation, day12, donor2	13024-139D9	319.73	26.37	27.63	0.00	0.25	6.53
Adipocyte differentiation, day12, donor3	13027-139E3	342.30	24.22	35.34	0.00	0.33	5.89
Adipocyte differentiation, day12, donor4	13030-139E6	287.42	18.27	32.88	0.30	0.00	4.57
Alveolar Epithelial Cells, donor1	11510-119G7	317.35	36.69	30.94	0.00	0.00	9.28
Alveolar Epithelial Cells, donor2	11590-120G6	116.54	8.96	11.83	0.00	0.00	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	207.26	14.38	22.76	0.00	0.00	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	290.55	39.04	38.50	0.00	0.00	10.07
Amniotic Epithelial Cells, donor2	11613-122A2	197.47	35.14	30.12	0.00	0.00	10.04
Amniotic Epithelial Cells, donor3	11694-123A2	252.70	32.26	48.90	0.00	0.00	9.86
Anulus Pulposus Cell, donor1	11248-116E6	204.82	54.92	54.81	0.00	0.00	9.27
Anulus Pulposus Cell, donor2	11463-119B5	179.76	31.35	49.96	0.00	0.73	4.65
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	272.72	66.05	26.96	0.00	0.00	10.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	284.36	55.14	30.39	0.43	0.43	10.42
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	342.44	53.51	42.80	0.00	2.14	14.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	270.82	57.09	26.60	0.30	0.00	11.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	303.52	60.70	18.97	0.00	0.00	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	247.53	32.34	48.85	0.00	0.00	15.18
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	267.06	53.93	33.14	0.00	0.32	7.15
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	277.67	55.83	29.13	0.00	0.00	10.68
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	297.53	33.26	36.23	0.59	0.59	8.91
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	297.17	60.64	26.74	0.38	0.00	7.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	256.16	54.43	32.66	0.00	0.00	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	230.69	52.66	35.11	0.00	1.25	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	269.01	49.59	37.72	0.16	0.00	10.38
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	326.19	70.97	28.66	0.00	0.00	10.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	230.26	39.66	31.97	0.45	0.15	8.44
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	280.22	49.83	31.61	0.00	0.00	6.43
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	215.01	45.16	29.47	0.57	0.00	7.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	261.94	43.30	29.67	0.27	0.27	7.48
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	270.20	48.77	34.14	0.00	0.00	9.75
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	228.06	44.28	29.19	0.17	0.17	9.12
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	324.20	46.83	34.82	1.20	0.00	9.61
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	307.99	56.64	21.24	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	216.30	38.25	31.39	0.17	0.69	5.15
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	364.96	29.36	33.56	0.00	0.00	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	307.27	56.79	28.64	0.49	0.97	8.74
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	279.66	49.71	31.11	0.00	0.38	9.11
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	264.08	54.51	33.92	0.00	0.00	9.69
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	312.95	66.69	34.20	1.14	0.00	13.11
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	234.94	40.40	29.29	0.00	0.21	8.55
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	240.54	39.75	37.42	0.00	0.00	7.74
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	289.03	64.28	25.81	0.00	0.00	12.20
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	230.55	41.16	37.30	0.00	0.32	7.72
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	271.83	42.81	42.81	0.00	0.71	12.84
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	286.04	43.87	31.59	0.58	0.58	7.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	258.92	41.25	37.94	0.00	0.60	10.24
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	312.44	36.83	49.90	0.00	1.19	11.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	328.02	71.20	31.02	0.00	1.02	9.66
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	232.53	40.75	34.89	0.00	0.76	6.37
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	243.98	43.21	34.95	0.00	0.00	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	287.40	53.51	32.37	0.00	0.43	9.49
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	240.48	40.01	31.96	0.21	0.00	7.41
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	273.74	36.83	30.45	0.58	0.58	8.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	299.48	59.52	39.68	0.00	0.00	8.50
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	227.67	41.19	31.19	0.51	0.34	7.97
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	294.18	39.38	25.48	0.00	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	373.93	86.62	40.14	0.00	0.00	19.01
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	244.00	39.67	29.59	0.00	0.21	7.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	306.85	37.90	32.49	0.00	0.00	8.42
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	312.00	65.61	29.16	0.00	0.00	14.58
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	259.08	55.63	30.11	0.23	0.23	12.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	255.03	40.80	25.50	0.00	2.55	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	274.57	40.93	41.19	0.25	0.00	8.64
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	259.91	46.86	30.55	0.62	0.00	8.67
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	247.25	34.27	29.68	0.00	0.61	7.34
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	283.94	59.27	31.07	0.00	0.48	12.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	233.71	39.47	28.83	0.22	0.22	7.98
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	250.23	56.45	33.57	0.00	0.00	9.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	290.79	57.60	31.57	0.00	0.00	10.52
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	222.96	32.83	33.89	0.00	0.00	5.56
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	263.14	31.62	29.08	0.00	0.00	3.63
Astrocyte - cerebellum, donor1	11500-119F6	209.28	68.65	41.51	0.00	0.49	10.69
Astrocyte - cerebellum, donor2	11580-120F5	174.93	35.09	44.50	0.00	0.17	7.87
Astrocyte - cerebellum, donor3	11661-122F5	125.85	30.20	30.83	0.00	0.00	8.81
Astrocyte - cerebral cortex, donor1	11235-116D2	358.00	75.64	59.61	0.00	0.00	18.48
Astrocyte - cerebral cortex, donor2	11316-117D2	378.87	62.44	53.39	0.00	0.16	14.24
Astrocyte - cerebral cortex, donor3	11392-118C6	350.08	56.83	61.01	0.00	0.45	13.87
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	96.79	39.11	32.34	0.00	0.00	10.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	99.47	37.58	30.07	0.00	0.00	11.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	90.81	38.01	28.34	0.00	0.00	10.58
Basophils, donor1	12241-129G9	57.01	20.92	23.01	3.66	0.00	3.14
Basophils, donor2	12242-129H1	73.96	27.42	29.59	13.71	0.00	4.33
Basophils, donor3	12243-129H2	63.80	17.49	19.70	4.12	0.00	6.17
Bronchial Epithelial Cell, donor1	11511-119G8	188.22	19.62	32.77	0.00	0.00	6.90
Bronchial Epithelial Cell, donor2	11591-120G7	133.04	12.34	16.46	0.00	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	286.94	14.35	64.56	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	230.35	20.71	34.52	0.00	0.00	5.02
Bronchial Epithelial Cell, donor5	11457-119A8	214.19	21.21	33.90	0.00	0.00	4.16
Bronchial Epithelial Cell, donor6	11461-119B3	315.96	34.08	46.06	0.00	0.00	9.21
Bronchial Epithelial Cell, donor7	11769-123I5	233.03	30.59	47.33	0.00	0.18	7.56
Burkitt's lymphoma cell line:DAUDI	10422-106C8	161.90	196.42	15.56	0.41	0.21	25.56
Burkitt's lymphoma cell line:RAJI	10476-106I8	214.50	109.00	37.96	0.70	0.00	28.41
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	206.89	194.42	38.37	0.96	0.00	27.50
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	279.23	62.05	0.00	0.00	20.68
CD14+ Monocytes, donor1	11224-116B9	39.45	18.60	17.47	14.09	0.00	2.82
CD14+ Monocytes, donor2	11305-117B9	52.52	14.66	21.53	11.51	0.00	3.90
CD14+ Monocytes, donor3	11381-118B4	54.01	14.49	22.39	11.85	0.00	3.51
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	94.54	27.74	22.93	0.00	0.00	7.93
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	91.36	22.37	21.99	0.00	0.38	6.82
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	93.03	18.08	22.68	0.00	0.00	7.89
CD14+ monocytes - mock treated, donor1	11863-125A9	72.27	15.61	21.25	0.14	0.00	3.61
CD14+ monocytes - mock treated, donor2	11873-125C1	61.56	14.18	15.39	0.00	0.00	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	61.36	13.27	22.50	0.47	0.00	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	62.27	13.56	18.25	0.84	0.33	4.02
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	49.41	9.38	13.25	0.28	0.28	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	71.40	11.65	20.33	0.00	0.00	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	58.15	13.31	20.17	0.00	0.00	4.70
CD14+ monocytes - treated with BCG, donor2	11870-125B7	56.26	13.71	17.98	0.36	0.53	2.85
CD14+ monocytes - treated with BCG, donor3	11880-125C8	82.92	23.72	27.86	0.00	0.00	3.26
CD14+ monocytes - treated with Candida, donor1	11868-125B5	67.90	17.79	23.41	0.70	0.00	3.04
CD14+ monocytes - treated with Candida, donor2	11878-125C6	64.42	11.62	22.18	1.58	0.00	4.22
CD14+ monocytes - treated with Candida, donor3	11888-125D7	90.97	16.64	17.75	0.00	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	67.68	16.96	23.95	0.59	0.00	3.87
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	55.87	13.77	17.16	0.20	0.00	3.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	69.75	15.20	22.49	0.21	0.00	2.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	81.22	18.30	18.07	1.37	0.00	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	52.03	11.99	15.38	0.45	0.23	2.94
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	58.92	11.35	20.08	0.44	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	68.32	13.72	20.44	0.54	0.27	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	65.77	19.19	19.37	0.35	0.17	2.97
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	64.81	18.94	19.78	0.00	0.42	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	62.65	20.76	21.31	1.47	0.00	4.23
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	57.07	11.62	15.15	0.00	0.00	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	59.23	10.97	15.36	0.44	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	62.08	13.95	20.23	0.35	0.00	4.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	51.66	11.15	19.70	0.37	0.00	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	82.34	21.12	31.47	1.29	0.00	3.45
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	97.87	17.20	25.80	1.23	0.00	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.10	13.21	18.08	0.46	0.00	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	65.42	16.24	23.43	0.93	0.23	3.94
CD14+CD16+ Monocytes, donor1	11789-124B7	74.76	20.49	25.50	0.00	0.00	4.14
CD14+CD16+ Monocytes, donor2	11801-124D1	106.03	18.71	22.41	0.00	0.00	5.31
CD14+CD16+ Monocytes, donor3	11912-125G4	95.31	30.76	35.31	0.00	0.00	6.93
CD14+CD16- Monocytes, donor1	11788-124B6	120.53	27.87	37.84	0.62	0.00	9.19
CD14+CD16- Monocytes, donor2	11799-124C8	123.47	30.39	32.13	0.35	0.00	8.21
CD14+CD16- Monocytes, donor3	11910-125G2	77.82	24.53	29.43	0.00	0.00	5.35
CD14-CD16+ Monocytes, donor1	11790-124B8	81.40	16.59	28.32	0.00	0.00	5.61
CD14-CD16+ Monocytes, donor2	11800-124C9	88.92	12.52	23.49	0.22	0.22	4.17
CD14-CD16+ Monocytes, donor3	11911-125G3	78.32	15.58	28.21	0.21	0.00	4.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	75.20	36.58	0.00	0.00	20.32
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	97.63	58.98	18.31	0.00	0.00	13.56
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	84.92	57.99	18.64	0.00	0.00	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	76.76	53.30	17.59	0.00	0.00	9.06
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	75.59	70.22	19.83	0.00	0.00	8.04
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	75.81	53.35	16.85	0.00	0.00	11.23
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	80.79	69.02	17.26	0.00	0.00	8.63
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	108.10	72.51	15.82	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	55.07	26.30	14.79	3.29	0.82	4.11
CD19+ B Cells, donor2	11624-122B4	59.49	25.39	15.23	2.90	0.00	7.25
CD19+ B Cells, donor3	11705-123B4	54.02	32.81	11.61	2.02	0.00	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	724.07	70.31	129.30	0.00	0.40	19.39
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	677.94	75.10	132.23	0.00	0.00	16.38
CD34+ Progenitors, donor1	11545-120B6	111.45	122.49	33.13	1.00	0.00	18.07
CD34+ Progenitors, donor2	11625-122B5	106.18	108.99	25.28	15.17	0.00	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	179.24	169.47	41.33	0.38	0.00	26.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	195.04	182.19	40.59	0.23	0.00	25.25
CD4+ T Cells, donor1	11225-116C1	87.48	29.64	27.85	20.35	0.00	8.93
CD4+ T Cells, donor2	11306-117C1	84.51	22.05	34.29	49.60	1.22	4.29
CD4+ T Cells, donor3	11382-118B5	88.45	22.57	26.53	35.07	0.00	5.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	96.22	27.82	36.24	0.26	0.00	9.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	106.91	28.52	48.29	0.00	0.00	7.64
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	95.72	34.21	42.26	0.00	0.00	6.61
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	160.72	85.34	53.57	5.22	0.00	15.65
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	219.12	109.56	54.78	1.40	0.00	14.75
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	197.77	69.22	79.11	6.59	0.00	26.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	65.18	23.99	30.20	0.72	0.00	6.50
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	61.68	13.22	38.98	0.51	0.51	6.27
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	54.33	13.70	27.73	0.97	0.00	5.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.59	34.97	31.38	4.48	0.00	6.28
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	104.12	35.64	33.89	3.14	0.35	9.43
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	68.64	26.84	29.48	1.32	0.00	7.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	129.87	34.57	34.57	0.42	0.00	8.85
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	118.43	27.63	49.03	0.21	0.21	7.90
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	141.34	34.42	57.47	0.67	0.33	9.36
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	134.06	60.37	32.63	2.72	0.00	11.42
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	164.54	65.92	39.12	0.54	0.54	15.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	116.56	46.62	23.31	0.00	0.00	19.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	87.34	26.52	32.45	0.00	0.00	9.09
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	74.73	22.31	30.54	0.65	0.22	7.36
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	75.65	22.49	29.84	0.84	0.00	9.04
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	92.02	43.99	29.83	22.75	0.00	9.61
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	95.32	45.49	37.69	8.23	0.00	13.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	68.86	31.38	33.56	4.36	0.00	6.10
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	147.47	68.29	41.07	0.00	0.00	11.38
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	159.71	80.32	42.47	0.00	0.00	12.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	147.96	83.75	36.29	0.00	0.00	18.15
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	137.63	74.77	32.12	0.28	0.28	7.48
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	159.75	87.60	38.77	0.49	0.00	11.04
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	180.18	77.00	41.58	0.00	0.00	18.48
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	120.33	59.81	38.68	0.00	0.00	12.18
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	159.27	78.94	45.70	1.38	1.38	12.46
CD8+ T Cells, donor1	11226-116C2	80.21	47.80	22.26	65.48	0.00	10.80
CD8+ T Cells, donor2	11307-117C2	111.13	33.04	22.90	87.85	0.00	7.51
CD8+ T Cells, donor3	11383-118B6	123.21	50.25	28.28	64.64	0.00	9.59
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.48	20.42	21.10	0.00	0.23	3.90
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	63.98	21.33	16.77	0.00	0.24	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	67.30	28.73	18.88	0.27	0.27	5.47
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	89.76	36.63	27.32	0.00	0.00	9.31
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	62.16	20.16	24.72	0.00	0.00	4.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	66.85	23.65	23.88	0.00	0.23	5.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	89.96	29.33	20.64	0.22	0.00	8.91
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	95.81	33.43	21.85	0.00	0.00	9.48
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	85.36	26.73	19.93	0.00	0.00	6.33
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	99.32	34.72	22.94	0.00	0.00	9.36
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	100.81	29.34	20.92	0.00	0.29	7.55
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	88.72	29.84	22.11	0.27	0.00	9.59
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	87.11	23.64	11.38	1.75	0.00	5.25
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	93.82	25.50	14.57	0.91	0.00	5.47
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	92.49	16.41	16.41	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.83	34.94	18.01	0.00	0.00	7.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	61.28	23.88	22.44	0.00	0.00	8.92
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	62.70	24.28	17.91	0.00	0.00	6.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	81.76	29.16	19.33	0.00	0.00	8.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	81.81	34.45	23.07	0.00	0.00	7.07
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	69.89	31.42	22.76	0.00	0.00	5.77
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	84.52	38.63	16.83	0.00	0.00	9.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	74.09	29.56	16.16	0.00	0.00	9.46
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	77.91	22.69	22.69	0.00	0.76	6.81
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	141.32	35.33	13.65	3.21	0.00	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	135.69	20.98	14.69	0.70	0.70	9.79
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	152.27	32.06	20.04	1.00	0.00	11.02
Cardiac Myocyte, donor1	11525-119I4	544.67	47.52	53.00	0.00	3.66	20.11
Cardiac Myocyte, donor2	11605-120I3	617.61	64.73	72.63	0.49	0.49	9.39
Cardiac Myocyte, donor3	11686-122I3	697.27	75.77	74.29	0.11	0.11	18.21
Chondrocyte - de diff, donor1	11261-116G1	223.60	48.19	36.40	0.00	0.69	9.01
Chondrocyte - de diff, donor2	11338-117F6	173.07	46.55	30.21	0.00	0.00	5.69
Chondrocyte - de diff, donor3	11410-118E6	194.56	44.03	47.45	0.00	0.11	8.31
Chondrocyte - re diff, donor2	11339-117F7	391.23	45.66	37.60	2.69	0.00	11.64
Chondrocyte - re diff, donor3	11411-118E7	218.38	40.44	38.82	0.40	0.00	8.09
Ciliary Epithelial Cells, donor1	11242-116D9	269.68	92.38	56.46	0.00	0.11	18.82
Ciliary Epithelial Cells, donor2	11323-117D9	248.18	63.27	49.81	0.00	0.00	14.11
Ciliary Epithelial Cells, donor3	11399-118D4	225.49	54.43	45.66	0.09	0.00	12.66
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	269.51	59.24	37.05	0.00	0.09	18.07
Corneal Epithelial Cells, donor1	11526-119I5	140.97	23.71	32.72	0.00	0.00	6.59
Corneal Epithelial Cells, donor2	11606-120I4	253.68	23.89	37.54	0.00	0.00	3.41
Corneal Epithelial Cells, donor3	11687-122I4	219.08	31.44	39.62	0.00	0.26	12.01
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	151.89	22.12	30.54	0.00	0.00	5.94
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	152.03	20.82	31.86	0.00	0.32	9.46
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	148.38	31.06	10.35	0.00	0.00	13.80
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	119.54	17.93	27.97	0.00	0.00	5.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	166.38	115.82	15.37	2.39	0.00	20.50
Dendritic Cells - plasmacytoid, donor2	11309-117C4	156.69	150.16	16.32	2.61	0.00	19.59
Dendritic Cells - plasmacytoid, donor3	11385-118B8	162.61	139.38	12.58	3.87	0.00	15.49
Endothelial Cells - Aortic, donor0	11207-116A1	340.88	39.36	27.85	0.00	0.17	8.17
Endothelial Cells - Aortic, donor1	11263-116G3	293.39	28.75	28.17	0.00	0.00	8.21
Endothelial Cells - Aortic, donor2	11340-117F8	295.52	39.31	19.80	0.00	0.00	11.03
Endothelial Cells - Aortic, donor3	11412-118E8	250.46	27.92	29.10	0.00	0.00	10.22
Endothelial Cells - Artery, donor1	11264-116G4	259.46	34.32	26.47	0.00	0.00	9.31
Endothelial Cells - Artery, donor2	11341-117F9	270.81	50.58	29.41	0.24	0.00	11.53
Endothelial Cells - Artery, donor3	11413-118E9	322.57	33.83	25.95	0.35	0.00	8.24
Endothelial Cells - Lymphatic, donor1	11236-116D3	186.19	34.13	18.18	0.00	0.44	11.08
Endothelial Cells - Lymphatic, donor2	11317-117D3	196.86	35.29	21.91	0.00	0.00	7.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	122.06	37.21	14.94	0.00	0.00	9.87
Endothelial Cells - Microvascular, donor1	11265-116G5	206.21	36.55	23.77	0.00	0.00	8.02
Endothelial Cells - Microvascular, donor2	11342-117G1	214.51	29.16	27.07	0.00	0.00	6.77
Endothelial Cells - Microvascular, donor3	11414-118F1	95.56	21.55	18.15	0.00	0.14	6.52
Endothelial Cells - Thoracic, donor1	11266-116G6	328.90	41.21	25.21	0.00	0.00	8.40
Endothelial Cells - Thoracic, donor2	11343-117G2	204.93	32.50	17.82	0.52	0.00	12.58
Endothelial Cells - Umbilical vein, donor1	11243-116E1	357.95	74.30	41.62	0.00	0.25	17.77
Endothelial Cells - Umbilical vein, donor2	11324-117E1	192.06	31.50	28.90	0.00	0.00	8.69
Endothelial Cells - Umbilical vein, donor3	11400-118D5	195.04	28.09	25.28	0.00	0.00	7.45
Endothelial Cells - Vein, donor1	11267-116G7	338.98	30.71	25.03	1.14	0.00	9.10
Endothelial Cells - Vein, donor2	11344-117G3	310.83	48.90	16.07	0.00	0.00	5.59
Endothelial Cells - Vein, donor3	11416-118F3	254.98	38.47	28.42	0.00	0.16	10.83
Eosinophils, donor1	12244-129H3	45.74	30.49	0.00	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	41.26	13.20	19.80	18.15	0.00	0.00
Eosinophils, donor3	12246-129H5	67.77	10.70	21.40	24.97	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	174.45	25.90	28.83	0.00	0.24	8.80
Esophageal Epithelial Cells, donor2	11587-120G3	197.62	12.48	29.12	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	357.91	0.00	16.27	0.00	0.00	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	201.15	40.23	34.89	0.41	0.82	7.39
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	274.27	37.55	37.34	0.22	1.09	9.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	333.90	54.93	61.54	0.00	0.22	12.46
Fibroblast - Aortic Adventitial, donor1	11245-116E3	293.38	50.33	40.14	0.00	0.24	10.19
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	251.11	36.03	23.75	0.27	0.14	9.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	244.37	40.50	42.61	0.00	0.11	8.86
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	209.21	32.94	20.55	0.00	0.00	6.06
Fibroblast - Aortic Adventitial, donor3	11401-118D6	198.32	31.56	43.85	0.00	0.00	7.97
Fibroblast - Cardiac, donor1	11268-116G8	233.62	46.27	34.02	0.00	0.00	7.26
Fibroblast - Cardiac, donor2	11345-117G4	253.91	62.91	25.77	0.00	0.00	9.10
Fibroblast - Cardiac, donor3	11417-118F4	157.24	38.33	25.39	0.47	0.16	6.62
Fibroblast - Cardiac, donor4	11452-119A3	310.69	53.35	49.41	0.00	0.00	10.61
Fibroblast - Cardiac, donor5	11456-119A7	244.80	37.82	29.57	0.13	0.38	7.23
Fibroblast - Cardiac, donor6	11460-119B2	264.23	39.57	31.38	0.15	0.30	7.28
Fibroblast - Choroid Plexus, donor1	11492-119E7	220.95	61.37	29.61	0.00	0.13	7.77
Fibroblast - Choroid Plexus, donor2	11572-120E6	169.12	44.01	40.55	0.00	0.00	5.61
Fibroblast - Choroid Plexus, donor3	11653-122E6	328.11	68.85	46.87	0.00	0.00	13.18
Fibroblast - Conjunctival, donor1	11531-120A1	268.23	47.51	35.75	0.00	0.23	11.76
Fibroblast - Conjunctival, donor3	11692-122I9	175.88	57.16	49.86	0.00	0.00	9.33
Fibroblast - Dermal, donor1	11269-116G9	277.98	33.10	59.87	0.00	0.00	6.10
Fibroblast - Dermal, donor2	11346-117G5	376.40	39.15	42.45	0.00	0.47	8.02
Fibroblast - Dermal, donor3	11418-118F5	332.44	36.99	60.44	0.48	0.12	10.03
Fibroblast - Dermal, donor4	11450-119A1	317.88	36.63	40.81	0.00	0.34	9.38
Fibroblast - Dermal, donor5	11454-119A5	415.55	40.12	43.26	0.00	0.35	10.29
Fibroblast - Dermal, donor6	11458-119A9	453.00	46.78	40.93	0.32	0.16	11.86
Fibroblast - Gingival, donor1	11237-116D4	229.89	33.94	47.68	0.21	0.00	8.95
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	411.60	46.37	45.85	0.26	0.00	8.91
Fibroblast - Gingival, donor2	11318-117D4	219.55	45.33	44.67	0.00	0.00	9.62
Fibroblast - Gingival, donor3	11394-118C8	138.84	29.39	42.16	0.10	0.00	6.28
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	210.90	42.59	15.58	0.00	0.00	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	215.67	28.90	27.14	0.35	0.53	6.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	272.04	40.07	43.03	0.31	0.16	10.45
Fibroblast - Gingival, donor6 (control)	11922-125H5	269.10	36.78	41.38	0.00	0.27	11.63
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	473.56	14.12	31.41	4.94	0.00	10.94
Fibroblast - Gingival, donor7 (control)	11924-125H7	284.30	36.41	40.95	0.15	0.44	9.80
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	174.67	38.86	43.77	0.14	0.27	10.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	255.80	31.81	30.17	0.11	0.00	8.34
Fibroblast - Gingival, donor9 (control)	11927-125I1	179.17	34.19	38.89	0.00	0.29	7.04
Fibroblast - Lung, donor1	11270-116H1	599.47	44.86	55.73	1.36	0.00	9.52
Fibroblast - Lung, donor2	11347-117G6	207.41	37.30	43.27	0.00	0.00	5.97
Fibroblast - Lung, donor3	11419-118F6	310.22	53.81	55.71	0.00	0.21	12.03
Fibroblast - Lymphatic, donor1	11506-119G3	723.90	57.48	57.48	1.67	0.00	8.33
Fibroblast - Lymphatic, donor2	11586-120G2	304.90	9.79	50.35	0.00	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	304.78	19.31	24.91	3.64	0.28	4.20
Fibroblast - Mammary, donor1	11540-120B1	617.07	46.28	66.17	4.87	0.00	17.46
Fibroblast - Mammary, donor2	11620-122A9	319.54	11.98	47.93	0.00	0.00	15.98
Fibroblast - Mammary, donor3	11701-123A9	643.28	41.69	35.74	0.00	0.00	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	257.02	58.39	45.39	0.19	0.00	11.25
Fibroblast - Periodontal Ligament, donor2	11319-117D5	222.82	40.95	37.62	0.15	0.15	9.71
Fibroblast - Periodontal Ligament, donor3	11395-118C9	235.61	24.17	30.60	0.00	0.31	8.26
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	159.90	38.16	26.71	0.00	0.00	8.40
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	266.48	44.82	35.91	0.27	0.00	11.88
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	144.50	23.77	27.02	0.23	0.12	4.52
Fibroblast - Pulmonary Artery, donor1	11250-116E8	372.27	63.56	36.81	0.33	0.22	15.36
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	822.52	32.92	33.32	5.28	0.00	17.47
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	259.26	32.07	39.42	0.00	0.00	9.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	393.38	47.05	64.05	0.00	0.00	10.67
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1023.79	39.89	23.62	2.78	0.20	12.11
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	801.24	57.19	34.10	0.00	0.36	12.26
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	353.18	91.45	47.50	0.00	0.00	14.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	363.43	43.02	29.18	0.90	0.00	4.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	428.68	70.06	39.29	0.11	0.11	9.72
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1169.20	63.77	26.07	1.52	0.76	12.40
Fibroblast - skin normal, donor1	11553-120C5	1110.15	68.75	49.55	0.98	0.82	21.99
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	162.61	31.68	21.86	0.00	0.00	7.62
Fibroblast - skin normal, donor2	11561-120D4	316.36	78.96	42.50	0.10	0.10	11.35
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	480.26	66.79	25.69	0.30	0.00	12.09
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	436.35	78.95	42.75	0.33	0.25	14.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	232.49	123.94	49.75	0.00	0.34	9.23
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1306.17	47.62	29.89	0.66	0.66	15.44
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1601.98	69.77	44.63	1.07	1.07	21.20
Fibroblast - skin walker warburg, donor1	11554-120C6	518.53	58.36	40.82	0.17	0.00	16.36
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	880.39	78.57	51.28	1.25	0.63	16.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	421.04	221.60	66.48	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	187.38	6.10	70.59	0.00	0.87	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	166.42	16.99	26.35	0.00	0.00	5.20
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	179.57	25.76	25.76	0.00	0.26	8.33
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	139.00	17.89	22.23	0.00	0.00	7.15
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	706.60	137.80	86.51	0.00	0.00	29.09
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1003.05	170.37	89.97	0.00	1.91	43.39
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	906.28	153.76	98.13	0.00	2.00	33.09
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	459.69	127.12	115.82	0.00	1.65	35.02
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	456.20	122.61	90.19	0.00	0.91	39.04
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	744.77	109.96	86.19	0.20	0.99	28.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	471.04	140.89	105.21	0.00	0.53	25.90
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	440.62	107.30	92.30	0.00	0.33	29.68
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	993.23	136.20	94.19	0.00	3.54	28.30
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	390.47	113.48	47.91	0.00	0.42	25.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	351.57	68.34	44.58	0.00	0.25	17.73
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	361.84	87.03	37.61	0.00	0.00	20.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	348.76	93.66	39.27	0.12	0.12	18.21
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	387.32	98.97	47.90	0.00	0.28	17.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	335.25	78.07	36.19	0.00	0.00	19.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	302.79	67.77	44.49	0.00	0.23	14.15
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	255.73	77.98	36.50	0.00	0.25	13.58
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	243.93	50.93	33.22	0.00	0.22	14.21
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	322.96	93.67	45.50	0.00	0.59	19.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	275.95	89.65	39.10	0.00	0.16	13.67
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	306.98	63.67	37.76	0.00	0.00	15.64
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	265.75	73.80	42.34	0.00	0.00	12.10
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	296.36	94.83	37.66	0.00	0.00	18.32
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	430.59	81.49	38.13	0.09	0.00	21.64
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	282.10	97.40	51.30	0.00	0.21	19.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	282.98	106.91	48.16	0.00	0.00	18.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	205.37	82.22	43.60	0.00	0.11	14.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	344.68	89.77	39.19	0.00	0.08	19.47
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	351.60	94.74	40.22	0.20	0.20	15.31
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	239.93	91.39	42.09	0.00	0.00	15.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	208.34	94.77	45.54	0.00	0.00	16.37
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	193.61	66.37	32.02	0.00	0.00	13.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	172.38	61.94	39.02	0.00	0.00	11.68
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	190.64	93.84	43.05	0.00	0.12	14.39
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	206.99	57.22	35.17	0.32	0.16	11.83
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	196.92	76.97	54.20	0.32	0.64	12.83
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	137.11	58.65	30.80	0.00	0.38	10.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	166.08	51.41	35.12	0.00	0.00	10.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	179.11	64.77	39.23	0.00	0.61	7.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	155.45	68.58	30.42	0.00	0.21	12.02
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	172.13	65.43	33.15	0.00	0.00	8.34
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	192.18	56.11	32.54	0.00	0.00	9.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	103.23	47.31	22.31	0.00	0.19	8.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	185.04	58.83	34.23	0.00	0.00	10.43
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	138.16	44.68	28.46	0.15	0.46	7.19
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	138.73	54.79	25.52	0.13	0.00	8.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	148.55	43.10	32.80	0.00	0.00	7.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	139.74	44.98	30.42	0.00	0.37	9.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	149.79	46.71	30.70	0.00	0.00	8.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	101.16	38.68	32.73	0.00	0.00	7.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	180.06	43.00	32.45	0.26	0.13	8.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	162.82	40.96	25.42	0.20	0.20	7.67
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	138.52	41.94	33.29	0.00	0.25	10.42
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	727.17	148.90	55.74	0.00	0.80	21.10
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	391.97	102.46	41.91	0.00	0.31	24.50
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	455.61	147.30	45.83	0.00	0.00	36.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	639.63	160.22	61.65	0.63	1.25	35.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	630.66	155.41	68.94	0.00	0.57	32.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	473.20	124.06	52.12	0.00	1.38	24.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	584.05	91.57	71.77	0.00	2.47	19.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	536.12	117.59	59.57	0.00	0.39	20.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	688.32	99.48	93.06	0.00	6.42	19.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	558.16	139.11	59.12	0.00	0.00	12.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	511.33	113.27	53.05	0.00	0.00	18.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	547.28	140.42	65.48	0.00	0.82	23.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	479.85	93.30	56.65	0.00	0.00	23.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	478.48	129.20	56.77	0.00	0.28	19.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	517.72	120.61	42.49	0.00	0.33	17.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	441.23	113.24	54.52	0.00	0.00	11.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	531.18	134.86	64.57	0.00	0.32	23.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	517.64	136.54	56.72	0.00	0.00	19.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	684.91	202.55	75.17	0.00	0.00	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	624.24	165.51	75.60	0.00	0.57	24.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	591.97	136.74	63.34	0.00	0.59	24.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	665.80	101.65	60.99	0.00	5.08	22.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	707.47	126.75	70.42	0.00	0.41	20.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	584.53	142.45	54.54	0.23	0.69	20.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	779.74	100.10	89.56	0.00	0.00	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	585.84	104.56	72.27	0.00	0.38	20.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	586.75	112.79	66.17	0.00	0.65	22.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	651.45	98.99	76.25	0.00	0.67	12.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	617.58	160.66	81.29	0.00	0.77	25.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	722.34	121.87	71.55	0.34	0.34	22.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	591.38	99.39	74.54	0.00	4.97	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	562.92	140.14	87.29	0.00	0.00	19.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	602.89	102.59	69.40	0.00	0.00	23.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	695.87	115.47	79.86	0.51	0.00	23.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	590.28	148.37	83.76	0.00	0.80	19.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	684.78	150.47	87.32	0.00	0.00	22.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	872.35	165.26	92.07	1.18	0.00	25.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	675.05	158.11	85.77	0.00	0.00	23.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	673.68	121.57	82.07	0.00	0.00	22.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	519.64	116.13	79.68	0.00	0.85	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	557.52	130.72	69.24	0.00	0.60	17.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	638.59	129.08	65.02	0.97	2.43	13.10
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	322.99	33.10	38.80	0.00	0.00	7.99
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	251.57	26.20	40.33	0.00	0.42	7.90
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	699.41	47.23	73.09	2.25	0.00	17.99
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	162.70	39.33	49.79	0.00	0.00	5.71
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	240.62	41.36	57.65	0.00	0.00	6.27
Hep-2 cells mock treated, biol_rep1	11898-125E8	775.97	78.56	107.22	0.00	0.23	25.88
Hep-2 cells mock treated, biol_rep2	11899-125E9	715.21	72.25	120.69	0.00	0.34	22.28
Hep-2 cells mock treated, biol_rep3	11900-125F1	698.43	73.94	106.47	0.00	0.23	21.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	776.53	76.30	103.19	0.00	0.98	25.47
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	694.38	72.21	98.21	0.00	0.43	18.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	632.50	63.29	90.20	0.00	0.65	18.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	778.98	87.43	108.60	0.00	0.37	26.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	679.85	76.85	108.42	0.00	0.69	19.04
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	619.92	70.16	101.24	0.32	0.32	16.34
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	174.04	29.66	17.91	0.00	0.00	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	194.76	19.48	21.64	0.43	0.00	9.09
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	322.54	50.23	42.30	0.00	0.00	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	322.39	51.14	40.21	0.35	0.00	10.23
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	303.68	52.31	47.95	0.00	0.73	13.08
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	523.99	55.95	46.86	0.52	0.35	14.16
Hepatocyte, donor1	11523-119I2	509.66	9.68	59.32	0.00	0.00	2.42
Hepatocyte, donor2	11603-120I1	314.58	12.93	61.41	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	428.25	23.31	58.90	0.61	0.61	5.52
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	86.15	79.63	16.32	0.65	0.00	13.71
Intestinal epithelial cells (polarized), donor1	11246-116E4	418.08	40.20	34.08	0.17	0.17	8.74
Iris Pigment Epithelial Cells, donor1	11530-119I9	376.36	55.84	39.52	0.69	0.41	10.15
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	534.89	101.88	101.88	0.00	0.00	22.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	787.69	100.13	146.86	0.00	0.00	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1272.91	135.42	243.75	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	534.37	95.52	89.98	0.00	0.00	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	665.71	95.10	145.15	0.00	0.00	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1174.96	47.47	249.23	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	602.28	107.64	82.01	0.00	2.56	23.07
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	790.74	54.85	114.27	0.00	0.00	41.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	698.46	81.22	129.95	0.00	0.00	30.86
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	565.22	90.03	108.37	0.00	0.00	31.68
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	751.53	101.66	130.70	0.00	0.00	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	618.06	90.00	109.85	0.00	0.00	14.56
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	566.52	90.91	100.89	1.11	0.00	23.28
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	869.55	99.53	99.53	0.00	0.00	31.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	615.38	129.12	111.49	0.63	0.00	30.86
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	556.78	86.61	88.16	0.00	0.00	26.29
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	526.85	29.27	87.81	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	605.34	113.70	109.18	0.65	0.00	34.89
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	548.98	93.38	82.11	0.00	0.00	22.54
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	848.32	95.59	95.59	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	606.27	136.08	105.12	0.00	0.00	33.41
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	627.62	118.39	79.76	0.00	0.00	29.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	776.11	114.98	114.98	0.00	0.00	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	666.26	103.68	96.44	0.00	0.00	26.52
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	537.35	83.10	94.17	0.00	0.00	21.24
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	512.75	15.08	180.97	0.00	0.00	45.24
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	536.23	120.37	109.04	0.00	0.00	34.46
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	528.77	84.35	82.54	0.00	0.00	28.12
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	692.90	88.45	235.88	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	665.04	109.76	109.76	0.00	0.00	23.67
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	575.52	105.45	97.83	0.00	0.00	25.41
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	772.23	147.87	115.01	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	556.69	116.70	93.74	0.00	0.00	26.78
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	596.01	72.91	94.78	0.00	0.00	30.99
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	616.37	126.43	110.63	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	649.80	121.39	106.40	0.00	0.00	28.56
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	570.75	92.91	92.91	0.00	0.00	19.91
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	479.52	20.85	166.79	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	580.90	107.41	99.08	0.00	0.31	28.09
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	549.64	98.34	112.39	0.00	0.00	21.07
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	663.20	72.29	110.01	0.00	0.00	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	566.74	97.35	84.84	0.00	0.00	20.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	677.21	92.95	141.64	0.00	0.00	42.05
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	654.89	61.60	87.53	0.00	0.00	32.42
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	616.46	102.02	112.48	0.00	0.00	24.41
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	686.18	116.99	119.24	0.00	0.00	33.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	561.02	52.27	97.57	0.00	0.00	27.88
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	721.14	123.75	121.61	0.00	0.00	30.94
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	519.54	94.21	108.06	0.00	0.00	20.78
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	535.72	59.84	99.74	0.00	0.00	28.50
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	550.41	81.92	84.68	0.00	0.00	23.01
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	735.15	127.06	166.39	0.00	0.00	24.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	633.29	99.34	117.96	0.00	0.00	37.25
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	561.46	122.66	140.63	0.00	0.00	20.09
Keratinocyte - epidermal, donor1	11272-116H3	171.77	24.64	30.44	0.00	0.16	7.75
Keratinocyte - epidermal, donor2	11349-117G8	186.23	34.55	22.25	0.00	0.00	5.86
Keratinocyte - epidermal, donor3	11421-118F8	166.97	23.76	26.03	0.00	0.00	6.06
Keratinocyte - oral, donor1	11251-116E9	363.37	70.83	58.46	0.00	0.00	19.75
Keratocytes, donor1	11527-119I6	355.52	49.86	35.07	0.00	0.00	14.78
Keratocytes, donor2	11607-120I5	251.94	42.18	46.87	0.00	0.00	3.52
Keratocytes, donor3	11688-122I5	192.66	34.97	38.33	0.00	0.00	7.51
Krukenberg tumor cell line:HSKTC	10687-109F3	72.53	2.20	26.37	0.00	0.00	6.59
Lens Epithelial Cells, donor1	11529-119I8	309.60	42.07	40.99	0.00	0.00	5.39
Lens Epithelial Cells, donor2	11609-120I7	207.14	79.46	38.64	0.00	0.00	11.99
Lens Epithelial Cells, donor3	11690-122I7	346.12	66.90	36.73	1.11	0.00	13.32
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	157.83	37.23	27.27	0.00	0.12	9.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	146.51	32.09	24.84	0.00	0.00	8.09
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	148.12	39.20	24.56	0.00	0.16	9.92
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	158.63	39.79	22.58	0.00	0.54	6.45
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	147.50	32.78	26.16	0.00	0.32	7.56
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	126.36	36.55	22.32	0.00	0.00	10.57
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	118.19	28.73	20.93	0.00	0.00	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	164.59	41.21	27.56	0.00	0.00	10.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	128.36	38.28	25.34	0.00	0.14	9.57
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	145.16	34.41	21.36	0.00	0.00	10.68
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	142.50	36.06	27.34	0.00	0.00	10.47
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	132.57	39.81	20.92	0.00	0.19	6.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	133.45	32.40	23.69	0.00	0.00	7.32
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	145.98	40.07	23.61	0.00	0.00	10.97
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	142.29	31.04	23.62	0.00	0.00	9.20
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	133.96	32.34	24.33	0.00	0.00	7.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	151.51	34.29	25.56	0.00	0.00	11.22
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	142.92	38.06	25.07	0.00	0.00	8.60
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	142.18	30.28	26.99	0.00	0.00	6.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	163.42	39.24	27.53	0.00	0.00	10.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	161.31	42.82	24.40	0.25	0.00	10.46
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	159.55	30.55	25.22	0.00	0.00	5.82
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	173.97	39.05	24.24	0.00	0.00	10.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	143.35	37.24	24.83	0.00	0.30	9.23
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	161.74	43.03	24.37	0.00	0.00	11.92
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	141.76	39.57	26.17	0.00	0.00	8.38
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	132.18	37.14	21.05	0.00	0.00	11.28
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	167.84	37.83	33.71	0.00	0.00	8.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	148.07	39.70	26.53	0.00	0.00	9.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	114.19	37.00	20.89	0.00	0.11	8.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	119.21	22.78	24.23	0.00	0.00	7.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	148.19	33.74	25.14	0.00	0.00	9.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	129.34	38.03	22.55	0.00	0.00	9.04
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	151.42	38.13	27.03	0.00	0.00	7.77
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	153.69	41.26	27.18	0.00	0.00	10.13
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	131.99	34.79	23.37	0.14	0.00	6.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	139.27	34.09	22.51	0.00	0.00	7.40
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	159.77	37.13	28.30	0.00	0.61	11.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	140.67	37.37	22.81	0.00	0.00	8.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	132.27	32.00	21.69	0.00	0.00	11.02
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	197.30	44.11	23.27	0.00	0.00	9.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	129.15	35.63	25.99	0.00	0.16	9.34
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	150.76	37.96	26.86	0.00	0.36	8.95
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	164.97	38.22	22.21	0.00	0.00	8.82
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	151.38	41.67	26.13	0.00	0.00	11.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	142.31	36.51	26.48	0.00	0.12	10.27
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	141.64	36.63	21.26	0.00	0.26	10.76
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	108.90	35.21	22.08	0.00	0.00	7.76
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	242.46	79.31	43.05	0.00	0.00	13.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	253.15	51.40	52.17	0.00	0.00	13.81
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	249.39	65.32	60.86	0.00	0.00	10.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	326.23	68.55	69.82	0.00	0.00	19.04
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	248.98	55.56	56.97	0.00	0.00	18.29
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	263.38	57.91	86.86	0.00	0.93	17.75
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	289.07	67.50	65.44	0.00	0.00	12.88
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	248.60	73.75	61.85	0.00	0.00	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	275.05	82.11	67.18	0.23	0.23	20.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	296.64	69.51	56.71	0.29	0.58	15.12
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	237.69	54.47	60.32	0.00	0.45	18.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	272.19	76.96	65.98	0.27	0.14	21.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	338.93	66.76	68.30	0.00	0.00	12.84
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	206.07	53.28	54.34	0.00	0.00	13.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	211.22	57.97	47.31	0.00	0.00	14.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	300.03	75.90	72.84	0.00	0.00	19.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	234.79	65.37	58.96	0.00	0.00	9.34
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	256.97	69.53	64.81	0.19	0.00	17.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	323.96	79.76	73.01	0.00	0.00	23.93
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	295.18	52.19	73.39	0.00	0.00	14.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	247.81	63.31	56.64	0.00	0.00	13.95
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	282.78	66.98	62.50	0.00	0.28	18.78
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	254.49	59.76	46.37	0.00	0.00	17.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	250.82	61.54	68.51	0.29	0.29	16.26
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	288.17	60.38	60.68	0.00	0.00	18.23
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	215.22	52.56	60.86	0.00	0.00	16.04
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	285.97	69.64	59.39	0.00	0.00	16.97
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	284.70	62.69	74.49	0.00	0.00	19.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	265.94	81.74	49.50	0.00	0.00	13.82
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	291.65	72.91	66.01	0.00	0.38	13.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	304.58	74.73	65.67	0.00	0.00	19.81
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	246.14	73.02	73.84	0.00	0.00	11.49
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	308.64	72.30	71.40	0.00	0.00	9.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	359.07	71.10	57.45	0.00	1.44	11.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	239.76	64.23	60.50	0.00	0.00	18.67
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	279.07	69.12	56.85	0.37	0.00	18.21
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	285.59	69.78	60.74	0.00	0.00	16.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	236.34	50.52	62.51	0.86	0.00	18.84
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	264.54	75.30	59.31	0.00	0.00	17.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	317.94	76.02	58.52	0.00	0.00	18.70
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	241.74	61.15	62.57	0.00	0.00	12.80
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	279.44	71.15	71.49	0.00	0.34	17.53
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	300.58	88.03	68.70	0.00	0.54	19.86
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	250.49	65.99	51.85	0.00	0.00	27.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	295.22	65.93	68.16	0.00	0.00	19.26
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	231.42	103.50	67.45	0.00	0.00	11.63
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	270.78	67.70	65.58	0.00	0.00	9.52
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	286.11	69.23	66.02	0.40	0.40	15.21
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	315.46	62.51	66.87	0.00	0.00	19.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	327.30	55.96	83.55	0.00	0.00	28.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	312.24	75.96	82.87	0.00	0.00	20.72
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	270.99	64.92	53.63	0.00	0.94	16.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	272.03	61.34	56.82	0.00	0.00	25.14
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	265.42	72.10	73.00	0.00	0.45	12.62
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	370.04	98.10	75.73	0.00	0.00	13.77
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	272.55	81.94	58.79	0.00	0.00	19.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	275.67	56.70	77.03	0.00	0.00	12.12
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	292.26	60.04	56.74	0.00	0.66	11.88
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	277.11	66.94	64.35	0.00	0.00	22.83
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	220.10	65.20	58.63	0.00	0.44	16.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	291.29	73.80	62.06	0.00	0.00	14.54
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	254.83	66.69	68.90	0.00	0.00	11.92
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	280.41	49.76	65.57	0.00	0.39	15.43
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	306.34	70.89	63.80	0.51	0.00	16.20
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	248.96	57.67	66.81	0.00	0.00	12.98
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	281.07	65.60	71.96	0.00	0.40	16.30
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	296.52	55.29	54.08	0.00	0.61	10.33
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	262.85	63.64	60.18	0.00	0.00	8.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	269.03	67.26	68.78	0.00	0.00	10.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	332.57	64.55	66.10	0.00	0.00	13.94
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	287.21	53.81	53.21	0.00	0.00	7.86
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	269.37	61.48	55.77	0.00	0.00	16.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	310.79	48.51	61.84	0.00	0.53	16.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	329.29	74.13	54.59	0.00	0.00	12.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	287.97	64.28	44.74	0.00	0.00	15.94
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	323.97	62.25	70.03	0.00	0.00	21.22
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	298.50	82.85	67.53	0.00	0.57	11.92
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	272.08	77.38	71.14	0.00	0.00	15.81
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	372.73	84.57	66.56	0.00	0.78	21.14
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	314.41	75.16	62.63	0.00	0.84	10.44
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	291.79	62.26	71.09	0.00	0.00	15.33
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	340.55	59.55	76.27	0.00	0.00	19.40
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	312.23	63.09	64.69	0.00	0.53	6.42
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	269.94	70.31	72.33	0.00	0.00	11.72
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	335.90	63.33	65.16	0.00	0.00	16.52
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	308.52	75.57	51.57	0.00	0.89	12.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	282.09	70.09	66.10	0.00	0.00	17.67
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	286.05	71.32	72.09	0.00	0.00	18.41
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	290.00	58.55	69.49	0.00	0.55	12.04
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	264.15	69.49	61.47	0.00	0.00	17.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	272.69	74.87	57.45	0.00	0.00	21.84
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	356.75	82.89	56.36	0.00	0.00	12.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	340.89	81.07	103.93	0.00	2.08	27.02
Macrophage - monocyte derived, donor1	11232-116C8	71.57	16.64	18.46	0.23	0.00	5.70
Macrophage - monocyte derived, donor2	11313-117C8	184.06	17.62	31.38	0.18	0.00	7.34
Macrophage - monocyte derived, donor3	11389-118C3	106.83	14.55	28.31	0.00	0.00	5.90
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	247.99	15.93	34.52	0.00	0.53	9.56
Mallassez-derived cells, donor2	11929-125I3	190.14	27.57	26.94	0.00	0.00	6.18
Mallassez-derived cells, donor3	11930-125I4	178.60	35.02	31.83	0.28	0.14	8.20
Mammary Epithelial Cell, donor1	11273-116H4	278.70	53.21	58.99	0.00	0.20	17.54
Mammary Epithelial Cell, donor2	11350-117G9	267.25	39.09	51.54	0.00	0.00	10.42
Mammary Epithelial Cell, donor3	11422-118F9	197.80	21.45	39.41	0.00	0.00	8.98
Mast cell - stimulated, donor1	11487-119E2	548.45	67.79	82.03	1.36	0.00	11.52
Mast cell, donor1	11563-120D6	495.50	66.29	55.15	0.11	0.32	14.27
Mast cell, donor2	11565-120D8	478.15	56.17	61.81	1.49	0.00	13.37
Mast cell, donor3	11566-120D9	559.43	59.43	91.63	0.00	1.35	20.04
Mast cell, donor4	11567-120E1	460.95	50.17	64.00	0.35	0.89	10.46
Mast cell, expanded and stimulated, donor5	11940-126A5	398.88	59.00	67.09	0.11	0.33	16.30
Mast cell, expanded and stimulated, donor8	11942-126A7	451.77	47.86	46.69	0.00	0.58	14.59
Mast cell, expanded, donor5	11939-126A4	886.00	75.83	96.02	0.34	0.69	20.76
Mast cell, expanded, donor8	11941-126A6	578.09	55.23	56.57	0.33	0.50	9.21
Melanocyte - dark, donor1	11502-119F8	172.33	69.05	31.24	0.00	0.00	14.23
Melanocyte - dark, donor2	11582-120F7	592.49	72.33	87.21	0.00	0.00	11.42
Melanocyte - dark, donor3	11663-122F7	110.11	25.50	22.02	0.00	0.00	5.94
Melanocyte - light, donor1	11274-116H5	68.88	17.63	13.16	0.00	0.00	3.76
Melanocyte - light, donor2	11351-117H1	93.50	34.12	18.43	0.00	0.00	4.09
Melanocyte - light, donor3	11423-118G1	144.83	23.42	28.62	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	168.79	29.26	19.37	0.10	0.10	4.89
Melanocyte, donor2 (MC+2)	12739-135I3	162.98	28.51	22.32	0.00	0.27	5.92
Melanocyte, donor3 (MC+3)	12837-137B2	110.89	29.73	24.91	0.00	0.00	5.09
Meningeal Cells, donor1	11493-119E8	306.06	66.87	37.34	0.12	0.37	9.43
Meningeal Cells, donor2	11573-120E7	202.47	31.69	29.93	0.44	0.00	7.04
Meningeal Cells, donor3	11654-122E7	328.29	62.35	46.70	0.08	0.16	15.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	241.53	48.48	53.61	0.00	0.00	12.26
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	544.62	44.88	25.46	1.41	0.10	13.59
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	169.53	18.40	23.65	0.00	0.00	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	213.23	31.40	31.40	0.00	0.00	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	361.67	48.80	63.15	0.00	0.00	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	606.72	44.26	26.26	1.69	0.21	15.25
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	392.57	39.21	29.66	1.01	1.01	7.04
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	278.87	46.59	48.57	0.00	0.00	12.97
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	213.33	26.30	48.22	0.00	0.73	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	239.39	27.62	39.08	0.20	0.20	8.59
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	253.88	51.11	42.38	0.00	0.00	5.82
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	357.97	43.86	40.52	0.00	0.00	9.66
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	458.80	91.44	48.95	0.26	0.26	15.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	286.06	39.17	41.54	0.30	0.30	8.01
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	296.61	25.69	32.70	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	363.75	49.31	50.59	0.00	0.00	19.21
Mesenchymal stem cells - adipose, donor0	11217-116B2	292.42	64.86	52.10	0.00	0.00	17.37
Mesenchymal stem cells - hepatic, donor0	11218-116B3	344.62	94.13	44.09	0.31	0.00	21.58
Mesenchymal stem cells - umbilical, donor0	11214-116A8	447.03	51.52	52.98	0.73	0.00	10.16
Mesothelial Cells, donor1	11247-116E5	137.89	32.35	25.19	0.00	0.27	7.69
Mesothelial Cells, donor2	12156-128G5	165.65	40.54	19.52	0.50	0.00	9.01
Mesothelial Cells, donor3	11402-118D7	117.43	20.81	19.01	0.22	0.14	4.77
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	89.12	9.45	10.80	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	299.96	19.70	36.45	0.25	0.00	7.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	411.95	19.73	39.16	1.18	0.00	10.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	72.60	0.00	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	260.05	21.70	28.83	0.62	0.31	7.75
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	346.62	16.59	34.64	0.41	0.41	8.30
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	2.32	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	306.82	29.03	28.78	0.25	0.00	7.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	305.35	19.08	26.07	1.40	0.47	10.24
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	285.31	17.48	24.18	0.41	0.20	5.49
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	363.49	19.01	33.26	0.79	0.79	4.36
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	136.82	0.00	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	293.80	23.01	28.32	0.00	0.00	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	490.50	23.18	35.33	0.00	0.00	8.74
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	67.11	5.26	14.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	288.20	19.31	27.38	0.21	0.00	7.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	155.62	6.45	12.89	0.00	0.00	5.52
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	182.11	14.01	18.48	0.60	0.00	3.58
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	115.69	3.35	11.74	0.00	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	259.94	18.32	28.60	0.75	0.75	5.77
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	286.39	14.26	22.34	0.71	0.00	4.52
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	107.26	3.87	13.82	0.55	0.55	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	225.18	17.73	23.25	0.00	0.00	6.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	318.66	15.57	27.34	1.05	0.00	7.57
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	169.99	11.21	19.98	0.00	0.00	5.91
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	237.49	20.17	25.53	0.21	0.21	6.01
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	225.63	12.23	21.34	0.22	0.00	4.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	194.27	14.67	17.08	0.44	0.00	3.94
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	164.25	11.15	15.21	1.01	0.00	4.56
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	49.71	0.00	6.63	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	159.00	10.06	16.85	0.27	0.00	3.81
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	253.79	12.65	25.29	0.59	0.29	5.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	58.88	4.36	7.63	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	253.25	20.18	24.51	0.00	0.00	8.17
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	292.97	13.61	28.02	0.00	0.00	7.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	68.56	4.11	9.60	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	243.78	16.52	24.53	0.50	0.00	7.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	512.00	26.95	107.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	57.08	4.08	20.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	202.32	13.14	23.65	0.00	0.44	6.57
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	113.68	4.41	20.97	1.10	0.00	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	60.84	2.56	13.45	0.00	0.00	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	219.16	18.10	19.34	0.25	0.00	4.21
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	92.55	3.48	11.13	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	2.21	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	167.18	16.41	14.02	0.34	0.00	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	105.03	5.69	11.38	0.00	0.44	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.42	6.04	9.59	0.00	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	179.55	12.06	21.32	0.00	0.28	4.49
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	155.44	8.73	16.63	0.00	0.42	4.99
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	41.37	2.33	11.07	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	103.77	7.24	12.67	0.00	0.30	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	212.45	16.70	24.21	0.83	0.00	5.43
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	92.36	10.16	13.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	171.87	7.97	17.07	0.00	0.00	4.55
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	61.21	9.40	11.33	0.00	0.00	1.93
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	125.43	11.66	13.22	0.00	0.00	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	157.43	6.86	21.45	0.00	0.43	6.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	40.65	1.27	5.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	57.11	8.54	7.74	0.00	0.27	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	184.99	11.97	26.34	0.00	0.90	4.49
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	51.13	7.77	11.16	0.00	0.14	2.26
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	136.64	8.92	17.52	0.00	0.00	3.50
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	190.84	16.36	17.69	0.00	0.22	8.18
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	54.98	3.03	10.24	0.00	0.00	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	109.38	17.61	17.33	0.28	0.00	3.69
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	235.97	14.01	26.55	0.00	0.00	4.92
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	54.09	4.56	6.52	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	83.80	8.82	15.88	0.29	0.29	2.94
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	203.85	11.53	28.26	0.00	0.29	7.21
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	82.43	10.30	16.90	0.00	0.00	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	84.27	10.12	16.38	0.30	0.00	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	124.31	37.67	30.14	0.00	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	144.36	24.95	26.73	0.00	0.00	10.69
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	105.14	27.93	19.39	0.00	0.00	4.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	139.91	26.30	29.45	0.00	0.00	7.36
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	82.24	20.76	14.43	0.00	0.20	4.15
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	135.97	15.83	34.46	0.00	0.00	7.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	95.76	21.78	26.66	0.00	0.00	6.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	141.43	19.71	33.83	0.00	0.00	5.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	59.60	17.98	12.89	0.00	0.11	3.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	122.30	17.68	17.68	0.00	0.00	5.89
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	82.81	18.69	20.15	0.00	0.00	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	140.00	15.56	29.56	0.00	1.56	12.44
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	107.42	35.81	24.58	0.00	0.00	6.95
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	189.33	11.59	19.32	0.00	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	100.99	13.13	17.17	0.00	1.01	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	153.48	15.18	28.67	0.42	0.42	7.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	148.45	38.13	20.43	1.36	0.00	12.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	217.44	34.33	47.68	0.00	0.00	8.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	157.11	51.83	37.25	0.00	0.00	16.20
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	172.19	39.27	31.72	1.51	0.00	12.08
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	234.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	456.74	19.57	45.67	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	166.34	14.26	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	288.63	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	159.85	51.27	25.64	0.00	0.22	10.77
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	99.30	37.11	31.36	0.00	1.05	9.93
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	122.15	13.35	51.40	0.67	0.00	7.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	53.84	11.69	32.97	0.00	0.42	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	93.17	19.58	36.32	0.19	0.00	3.80
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	145.22	20.75	36.70	0.00	0.00	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	81.59	12.24	40.12	0.00	0.00	4.08
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	47.78	23.89	20.21	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	102.96	15.90	49.39	0.00	0.42	5.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	114.59	12.78	55.09	0.00	0.00	4.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	115.66	12.70	47.83	0.00	0.00	5.13
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	88.09	18.29	31.54	0.00	0.00	3.99
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	11.13	22.27	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	158.83	28.29	47.15	0.00	0.00	4.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	62.52	15.16	31.40	0.00	0.00	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	115.61	15.87	51.23	0.23	0.00	4.53
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	107.13	12.57	40.01	0.00	0.16	5.55
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	84.75	22.60	28.61	0.00	0.18	5.10
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	114.04	18.03	57.29	0.00	0.00	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	93.65	14.41	53.43	0.00	0.60	4.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	77.78	26.58	34.46	0.00	0.33	4.27
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	84.40	11.38	41.14	0.00	0.16	5.37
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	99.66	25.05	20.64	0.00	0.35	4.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	118.14	23.91	32.35	0.00	0.00	8.44
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	65.28	13.79	39.08	0.00	0.00	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	191.52	20.89	52.06	0.00	0.32	6.75
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	75.88	25.18	29.32	0.00	0.00	4.83
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	63.21	55.63	20.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	107.16	15.82	24.73	0.00	0.45	3.12
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	109.66	16.51	33.87	0.00	0.42	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	56.73	18.28	39.88	0.00	0.00	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	226.21	23.18	67.82	0.00	0.00	9.87
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	153.47	18.06	0.00	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	190.27	14.66	49.65	0.00	0.00	8.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	145.63	15.78	22.54	0.00	0.90	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	328.95	25.40	48.01	0.00	0.00	9.52
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	192.23	21.36	51.08	0.00	0.00	10.22
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	145.67	28.38	46.92	0.00	0.38	5.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	262.66	19.55	55.73	0.00	0.98	6.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	138.14	15.69	47.94	0.00	0.00	4.36
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	220.72	24.42	20.81	0.00	0.45	4.52
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	337.77	24.69	63.50	0.88	0.00	8.82
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	155.57	21.94	43.88	0.00	1.99	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	238.10	35.72	58.04	0.00	0.50	10.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	166.53	17.99	44.02	0.00	0.00	6.51
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	180.56	33.87	56.86	0.00	0.00	9.07
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	227.65	24.31	30.06	0.22	0.00	5.53
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	303.59	33.21	56.92	0.00	0.00	6.78
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	61.31	20.44	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	180.47	42.07	53.65	0.00	0.00	10.36
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	133.45	13.22	37.77	0.00	0.00	5.04
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	157.98	18.16	67.79	0.00	0.00	8.17
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	306.96	42.72	51.42	0.79	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	138.30	44.21	38.54	0.00	0.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	40.46	40.46	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	387.84	40.25	40.50	0.37	0.12	11.18
Myoblast, donor2	11322-117D8	253.16	35.86	52.93	0.19	0.00	8.06
Myoblast, donor3	11398-118D3	178.93	30.10	35.15	0.34	0.00	10.76
NK T cell leukemia cell line:KHYG-1	10777-110G3	177.16	42.76	38.38	4.23	0.29	9.05
Natural Killer Cells, donor1	11230-116C6	73.19	32.29	19.07	58.74	0.62	5.23
Natural Killer Cells, donor2	11311-117C6	79.31	34.98	26.84	83.53	0.00	8.14
Natural Killer Cells, donor3	11387-118C1	69.02	30.92	23.56	61.47	0.00	5.34
Neural stem cells, donor1	11275-116H6	495.41	65.69	59.89	0.00	0.73	19.96
Neural stem cells, donor2	11352-117H2	279.22	75.10	42.36	0.00	0.00	17.33
Neurons, donor1	11494-119E9	300.41	37.55	34.14	1.14	0.00	13.65
Neurons, donor2	11574-120E8	220.60	38.53	26.86	0.00	0.00	10.57
Neurons, donor3	11655-122E8	331.33	41.11	38.64	0.00	0.00	13.98
Neutrophils, donor1	11233-116C9	51.97	1.86	11.14	4.64	0.00	0.93
Neutrophils, donor2	11314-117C9	40.58	5.80	14.49	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	98.35	7.33	22.60	5.50	0.00	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	186.30	56.16	63.76	0.00	0.00	8.31
Nucleus Pulposus Cell, donor2	11409-118E5	190.15	22.79	58.28	0.00	0.00	7.16
Nucleus Pulposus Cell, donor3	11462-119B4	176.08	30.89	44.12	0.00	0.40	5.41
Olfactory epithelial cells, donor1	11933-125I7	171.38	40.33	37.17	0.14	0.28	6.33
Olfactory epithelial cells, donor2	11934-125I8	297.02	46.75	49.94	0.29	0.72	6.08
Olfactory epithelial cells, donor3	11935-125I9	263.33	37.23	40.75	0.34	0.34	7.15
Olfactory epithelial cells, donor4	11936-126A1	250.02	37.79	47.24	0.10	0.49	5.75
Oligodendrocyte - precursors, donor1	11496-119F2	269.62	42.13	27.68	0.00	0.00	10.23
Osteoblast - differentiated, donor1	11276-116H7	188.45	52.75	39.35	0.00	0.00	8.51
Osteoblast - differentiated, donor2	11353-117H3	116.60	17.15	46.87	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	159.52	23.59	36.62	0.62	0.00	4.34
Osteoblast, donor1	11277-116H8	356.67	75.44	61.17	0.00	0.00	18.18
Osteoblast, donor2	11354-117H4	275.31	47.76	52.67	0.00	0.00	12.64
Osteoblast, donor3	11426-118G4	194.08	31.64	42.66	0.00	0.18	11.02
Pancreatic stromal cells, donor1	11249-116E7	350.34	47.68	43.30	0.34	0.34	9.86
Pericytes, donor1	11491-119E6	106.48	36.16	16.13	0.00	0.00	4.01
Pericytes, donor2	11571-120E5	180.87	24.67	34.86	0.00	0.00	4.53
Pericytes, donor3	11652-122E5	606.89	41.30	38.86	1.83	0.20	11.80
Perineurial Cells, donor1	11499-119F5	238.36	59.11	37.18	0.11	0.11	13.68
Perineurial Cells, donor2	11579-120F4	587.12	83.18	65.51	0.18	0.09	16.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	78.09	27.41	25.18	15.94	0.00	8.61
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	78.36	18.61	29.38	12.49	0.00	3.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	62.12	21.35	20.84	19.02	0.00	4.40
Placental Epithelial Cells, donor1	11278-116H9	334.59	34.20	35.40	0.00	0.00	7.65
Placental Epithelial Cells, donor2	11355-117H5	467.95	41.03	44.36	0.00	0.00	12.20
Placental Epithelial Cells, donor3	11427-118G5	307.64	32.39	40.84	0.00	0.00	9.82
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	267.09	38.92	43.04	0.63	0.00	11.71
Preadipocyte - breast, donor1	11467-119B9	294.70	50.84	36.58	0.00	0.75	12.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	271.76	47.64	28.98	0.39	0.13	11.09
Preadipocyte - breast, donor2	11328-117E5	232.35	43.90	40.08	0.23	0.00	11.48
Preadipocyte - omental, donor1	11468-119C1	315.31	53.39	36.87	0.53	0.21	13.96
Preadipocyte - omental, donor2	11329-117E6	267.12	48.88	32.74	0.00	0.00	13.53
Preadipocyte - omental, donor3	11403-118D8	243.38	52.29	33.95	0.72	0.14	10.89
Preadipocyte - perirenal, donor1	11469-119C2	221.46	33.47	43.31	0.00	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	700.53	48.52	67.26	0.92	0.00	17.81
Preadipocyte - subcutaneous, donor2	11356-117H6	350.79	38.96	48.34	0.35	0.71	11.33
Preadipocyte - subcutaneous, donor3	11428-118G6	388.59	55.00	56.36	0.34	0.17	13.45
Preadipocyte - visceral, donor1	11280-116I2	302.36	54.49	55.14	0.00	0.00	15.00
Preadipocyte - visceral, donor2	11357-117H7	274.73	30.83	48.78	0.00	0.00	9.66
Preadipocyte - visceral, donor3	11429-118G7	254.75	38.87	47.96	0.21	0.00	7.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	394.18	44.20	27.91	0.15	0.00	11.01
Prostate Epithelial Cells, donor2	11331-117E8	106.57	11.10	21.67	0.00	0.14	3.52
Prostate Epithelial Cells, donor3	11404-118D9	108.02	6.37	33.37	0.00	0.12	2.45
Prostate Stromal Cells, donor1	11254-116F3	539.55	77.45	55.01	0.11	0.23	15.95
Prostate Stromal Cells, donor2	11332-117E9	610.15	52.00	45.36	0.18	0.54	16.67
Prostate Stromal Cells, donor3	11405-118E1	289.68	60.38	33.47	0.00	0.10	9.70
Renal Cortical Epithelial Cells, donor1	11516-119H4	163.15	47.81	36.86	0.00	0.36	12.41
Renal Cortical Epithelial Cells, donor2	11596-120H3	204.47	37.64	36.39	0.00	0.07	10.74
Renal Epithelial Cells, donor1	11517-119H5	119.20	29.42	29.42	0.00	0.00	8.12
Renal Epithelial Cells, donor2	11597-120H4	187.79	23.47	29.16	0.00	0.00	7.82
Renal Epithelial Cells, donor3	11678-122H4	251.64	50.50	41.18	0.00	0.00	14.29
Renal Glomerular Endothelial Cells, donor1	11514-119H2	181.11	14.98	21.79	0.00	0.00	4.77
Renal Glomerular Endothelial Cells, donor2	11594-120H1	332.60	33.29	25.87	0.13	0.27	7.41
Renal Glomerular Endothelial Cells, donor3	11675-122H1	206.47	42.63	37.52	0.00	0.22	9.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	55.23	19.96	9.98	0.00	0.00	5.99
Renal Mesangial Cells, donor1	11518-119H6	215.47	41.82	33.89	0.22	0.22	11.44
Renal Mesangial Cells, donor2	11598-120H5	211.92	47.02	44.52	0.00	0.00	8.78
Renal Mesangial Cells, donor3	11679-122H5	127.89	26.08	29.13	0.00	0.00	7.21
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	256.34	36.51	41.07	0.00	0.27	13.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	193.56	25.72	32.47	0.00	0.42	6.33
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	181.28	33.94	36.83	0.00	0.00	11.38
Retinal Pigment Epithelial Cells, donor0	11215-116A9	231.02	50.04	37.08	0.00	0.26	10.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	188.74	55.43	32.12	0.00	0.00	15.63
Retinal Pigment Epithelial Cells, donor2	11608-120I6	153.34	22.64	27.79	0.00	0.00	8.23
Retinal Pigment Epithelial Cells, donor3	11689-122I6	237.36	42.65	37.64	0.00	0.00	11.54
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	535.34	27.93	63.48	0.13	0.80	8.95
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	132.22	12.51	40.20	0.00	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	240.51	42.93	75.95	0.00	0.00	12.66
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	145.01	21.46	42.92	0.00	0.00	5.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	160.45	36.15	40.18	0.13	0.39	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	182.23	34.66	50.45	0.00	0.30	12.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	239.47	43.61	54.88	0.00	0.11	16.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	199.71	41.06	52.59	0.00	0.00	9.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	212.81	36.36	54.54	0.00	0.12	13.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	236.22	42.76	60.33	0.00	0.00	13.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	163.74	25.33	40.39	0.00	0.00	6.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	186.52	38.12	52.79	0.15	0.00	9.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	204.81	38.88	54.65	0.00	0.18	13.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	190.94	33.28	49.21	0.00	0.29	5.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	196.92	35.95	53.76	0.00	0.00	11.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	213.08	39.16	61.07	0.00	0.00	11.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	174.35	25.04	45.69	0.00	0.19	8.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	167.88	29.44	48.26	0.00	0.00	9.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	232.82	39.46	65.39	0.00	0.19	13.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	162.96	28.53	42.20	0.13	0.40	7.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	145.82	29.59	47.50	0.00	0.10	11.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	214.45	39.91	53.85	0.00	0.00	12.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	166.06	32.89	46.56	0.00	0.21	6.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	196.49	38.40	51.86	0.00	0.28	12.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	180.98	25.81	43.75	0.00	0.00	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	159.90	24.07	42.48	0.00	0.36	6.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	162.00	32.62	48.56	0.00	0.00	10.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	181.87	35.06	51.85	0.00	0.13	10.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	256.39	33.49	55.19	0.24	0.00	8.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	179.96	28.97	53.57	0.00	0.40	11.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	243.43	39.29	67.58	0.00	0.00	10.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	207.56	30.69	59.30	0.00	0.41	10.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	227.62	36.94	56.63	0.00	0.00	15.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	175.04	29.66	46.37	0.00	0.21	7.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	185.19	27.72	52.89	0.00	0.00	6.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	166.72	30.82	51.26	0.00	0.00	10.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	192.60	27.57	53.02	0.00	0.19	12.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	219.22	36.79	53.82	0.00	0.00	9.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	154.31	25.38	48.28	0.00	0.00	9.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	227.05	35.13	53.36	0.00	0.16	11.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	198.38	28.12	49.77	0.00	0.34	6.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	156.10	34.62	54.15	0.00	0.00	10.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	181.52	23.46	50.11	0.00	0.27	8.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	149.60	31.52	40.24	0.00	0.00	5.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	175.72	32.86	61.19	0.00	0.24	10.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	170.71	26.80	58.85	0.00	0.00	9.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	185.15	28.25	54.90	0.00	0.19	7.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	200.53	27.25	65.68	0.00	0.00	8.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	121.19	16.92	40.19	0.00	0.00	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	210.51	29.13	51.04	0.00	0.12	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	148.75	18.63	45.85	0.00	0.29	6.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	217.82	22.51	59.02	0.00	0.00	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	213.69	23.81	63.90	0.30	0.00	8.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	182.76	18.55	43.65	0.00	0.00	6.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	206.08	22.47	55.12	0.00	0.30	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	154.91	21.61	36.37	0.00	0.00	3.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	179.72	23.48	54.21	0.00	0.21	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	191.11	15.02	50.48	0.00	0.00	6.01
Schwann Cells, donor1	11498-119F4	179.80	23.89	27.83	0.00	0.00	7.15
Schwann Cells, donor2	11578-120F3	197.34	37.43	40.83	0.00	0.00	13.61
Schwann Cells, donor3	11659-122F3	219.74	37.68	44.47	0.00	0.22	9.64
Sebocyte, donor1	11220-116B5	142.42	31.22	31.77	0.00	0.00	10.41
Sebocyte, donor2	11301-117B5	152.57	17.92	28.95	0.00	0.00	6.89
Sebocyte, donor3	11378-118B1	198.49	25.76	37.72	0.00	0.00	6.60
Sertoli Cells, donor1	11255-116F4	437.34	54.67	24.85	0.00	1.66	13.25
Sertoli Cells, donor2	11333-117F1	409.53	36.72	36.72	0.00	0.00	11.30
Skeletal Muscle Cells, donor1	11281-116I3	191.70	40.21	45.31	0.00	0.00	9.94
Skeletal Muscle Cells, donor2	11358-117H8	620.20	52.04	36.14	0.00	0.00	10.84
Skeletal Muscle Cells, donor3	11430-118G8	381.23	63.54	56.85	0.00	0.00	11.70
Skeletal Muscle Cells, donor4	11451-119A2	397.13	62.84	62.52	0.00	0.47	11.31
Skeletal Muscle Cells, donor5	11455-119A6	404.61	59.01	71.80	0.00	0.45	15.61
Skeletal Muscle Cells, donor6	11459-119B1	364.60	55.56	54.33	0.00	0.00	12.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	318.42	89.59	63.38	0.00	0.13	20.79
Skeletal Muscle Satellite Cells, donor2	11321-117D7	271.39	52.08	62.50	0.00	0.29	9.70
Skeletal Muscle Satellite Cells, donor3	11397-118D2	299.81	46.13	47.52	0.10	0.10	12.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	882.96	79.70	68.41	0.25	0.51	25.44
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	298.19	36.19	37.64	0.72	0.00	12.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	263.36	52.98	41.42	0.14	0.28	7.16
Skin - palm, donor1	10286-104F7	134.31	10.74	45.66	0.00	0.00	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	120.95	11.82	17.73	0.00	0.43	3.17
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	279.72	23.72	40.08	0.82	0.00	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	187.08	21.03	26.35	0.00	0.00	6.49
Small Airway Epithelial Cells, donor1	11256-116F5	194.61	23.49	29.33	0.14	0.14	8.06
Small Airway Epithelial Cells, donor2	11334-117F2	97.05	10.55	17.02	0.00	0.00	4.36
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	187.98	21.14	23.68	0.00	0.21	10.36
Small Airway Epithelial Cells, donor3	11406-118E2	95.04	8.77	20.99	0.00	0.07	3.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	436.03	53.39	66.04	0.62	0.62	8.64
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	203.88	35.13	16.67	0.00	0.00	6.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	194.57	37.62	34.68	0.00	0.00	9.41
Smooth Muscle Cells - Aortic, donor1	11283-116I5	186.74	22.98	17.24	0.00	0.00	8.62
Smooth Muscle Cells - Aortic, donor2	11360-117I1	326.44	40.56	32.29	0.39	0.00	14.57
Smooth Muscle Cells - Aortic, donor3	11432-118H1	237.18	47.90	44.81	0.00	0.00	10.04
Smooth Muscle Cells - Bladder, donor1	11519-119H7	304.23	115.09	43.03	0.00	0.00	11.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	248.19	42.85	36.73	0.00	0.00	9.85
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	264.21	45.66	50.54	0.00	0.44	11.08
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	285.12	36.87	28.93	0.00	0.38	5.76
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	180.05	35.81	42.98	0.33	0.65	12.05
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	180.44	38.39	35.14	0.00	0.00	9.75
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	298.68	34.74	34.88	0.57	0.43	9.11
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	211.15	25.38	34.32	0.33	0.16	7.97
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	229.24	33.49	51.14	0.00	0.91	4.26
Smooth Muscle Cells - Carotid, donor1	11285-116I7	318.73	59.10	53.04	0.00	0.00	11.87
Smooth Muscle Cells - Carotid, donor2	11362-117I3	214.22	36.72	24.48	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	326.63	32.90	40.53	0.00	0.00	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	305.86	48.81	34.51	0.74	0.29	10.91
Smooth Muscle Cells - Colonic, donor2	11320-117D6	257.64	40.46	35.94	0.22	0.00	8.39
Smooth Muscle Cells - Colonic, donor3	11396-118D1	277.19	39.15	32.64	0.31	0.31	9.34
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	298.53	36.50	34.34	0.46	0.00	8.51
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	476.42	30.18	36.65	1.08	2.16	12.93
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	212.19	28.09	31.98	0.30	0.00	6.87
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	284.04	49.16	30.04	0.34	0.00	14.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	342.39	73.42	38.01	0.00	0.08	13.35
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	176.32	31.40	34.72	0.00	0.30	6.44
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	282.39	28.90	33.45	0.46	0.00	5.01
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	520.49	48.91	51.32	3.02	0.60	9.66
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	568.00	56.16	51.93	1.32	0.00	19.34
Smooth Muscle Cells - Prostate, donor1	11257-116F6	551.81	60.05	32.76	1.46	0.93	12.65
Smooth Muscle Cells - Prostate, donor2	11335-117F3	394.32	58.35	42.07	0.25	0.50	11.90
Smooth Muscle Cells - Prostate, donor3	11465-119B7	120.49	43.38	32.72	0.00	0.00	7.10
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	390.80	54.13	55.79	0.30	0.15	18.24
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	258.06	42.01	54.76	0.00	0.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	200.29	18.09	23.26	0.00	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	251.14	59.99	38.14	0.00	0.00	13.02
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	230.23	28.78	35.34	0.00	0.00	13.63
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	281.74	26.01	27.89	0.31	0.31	6.27
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	258.42	31.86	40.41	0.59	0.00	8.85
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	261.25	34.49	38.07	0.00	0.08	9.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	239.19	38.31	40.64	0.47	0.00	6.54
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	313.31	39.15	35.26	0.43	0.14	8.49
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	419.66	31.36	39.26	1.78	0.00	10.45
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	405.59	41.93	44.94	0.56	0.56	10.72
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	371.58	52.54	37.31	0.56	0.14	12.58
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	376.71	58.65	41.39	0.50	0.00	14.24
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	159.04	16.19	20.00	0.48	0.00	5.71
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	292.37	39.39	28.87	0.24	0.49	11.01
Smooth Muscle Cells - Uterine, donor1	11258-116F7	672.12	55.02	38.67	1.55	0.88	11.93
Smooth Muscle Cells - Uterine, donor3	11466-119B8	263.91	43.89	30.14	0.00	0.00	12.58
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	246.64	34.60	31.68	0.19	0.19	4.47
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	231.40	29.62	29.35	0.26	0.53	5.29
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	453.03	90.01	36.45	0.37	0.37	10.04
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	765.39	62.17	36.65	1.08	0.36	17.61
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	235.92	24.42	26.12	1.42	0.57	5.68
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	384.02	35.05	31.12	0.39	0.79	6.70
Smooth muscle cells - airway, control, donor1	11966-126D4	182.34	42.92	43.68	0.00	0.25	7.36
Smooth muscle cells - airway, control, donor2	11967-126D5	150.94	45.12	47.52	0.40	0.40	4.79
Smooth muscle cells - airway, control, donor3	11968-126D6	173.89	36.37	41.38	0.00	0.00	5.02
Smooth muscle cells - airway, control, donor4	11969-126D7	181.51	63.25	32.54	0.46	0.00	7.79
Synoviocyte, donor1	11291-117A4	164.95	45.11	28.61	0.00	0.00	11.11
Synoviocyte, donor2	11368-117I9	220.26	40.40	55.99	0.17	0.17	6.87
Synoviocyte, donor3	11440-118H9	168.00	32.39	39.32	0.00	0.22	6.26
Trabecular Meshwork Cells, donor1	11532-120A2	331.96	53.60	42.17	0.36	0.36	17.51
Trabecular Meshwork Cells, donor2	11612-122A1	166.49	17.84	27.75	0.00	0.00	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	161.39	24.08	21.77	0.23	0.23	8.80
Tracheal Epithelial Cells, donor1	11292-117A5	162.22	27.89	29.89	0.00	0.22	6.52
Tracheal Epithelial Cells, donor2	11369-118A1	226.53	35.18	42.14	0.39	0.00	7.34
Tracheal Epithelial Cells, donor3	11441-118I1	252.54	36.08	38.37	0.00	0.00	6.87
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	550.04	30.63	60.16	0.12	1.11	9.60
Urethra, donor2	10319-105A4	80.93	14.39	30.57	0.00	0.00	5.40
Urothelial Cells, donor1	11520-119H8	117.95	13.02	19.39	0.00	0.00	6.64
Urothelial Cells, donor2	11600-120H7	129.78	16.42	15.22	0.00	0.00	4.01
Urothelial Cells, donor3	11681-122H7	129.27	13.98	20.86	0.00	0.23	6.65
Urothelial cells, donor0	11216-116B1	159.37	39.01	22.07	0.00	0.00	9.58
Whole blood (ribopure), donor090309, donation1	12179-129A1	1209.22	81.86	169.95	1.78	0.00	15.13
Whole blood (ribopure), donor090309, donation2	12180-129A2	1359.56	70.05	208.72	0.00	0.00	17.16
Whole blood (ribopure), donor090309, donation3	12181-129A3	778.30	28.07	164.28	0.00	0.68	10.95
Whole blood (ribopure), donor090325, donation1	12176-128I7	780.27	33.40	146.34	0.00	0.00	12.05
Whole blood (ribopure), donor090325, donation2	12177-128I8	968.57	39.51	159.78	0.00	0.58	11.04
Whole blood (ribopure), donor090612, donation1	12182-129A4	910.04	51.02	122.87	0.00	0.00	9.37
Whole blood (ribopure), donor090612, donation2	12183-129A5	1106.86	65.16	167.04	0.00	0.00	8.26
Whole blood (ribopure), donor090612, donation3	12184-129A6	863.60	33.78	217.27	0.00	0.00	10.04
Wilms' tumor cell line:G-401	10809-111A8	317.04	67.36	40.96	0.00	0.49	21.59
Wilms' tumor cell line:HFWT	10597-108E3	117.05	19.36	34.32	0.00	0.88	7.04
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	275.41	41.62	68.15	0.28	0.28	11.45
achilles tendon, donor2	10292-104G4	107.46	18.60	33.06	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	185.86	58.38	46.15	0.25	0.25	22.95
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	137.68	184.11	19.97	0.00	0.23	24.84
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	124.41	66.83	29.08	0.00	0.12	18.99
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	92.79	83.54	27.48	0.27	0.54	23.67
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	357.26	186.64	56.50	0.00	0.00	42.44
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	214.86	109.76	38.28	0.21	0.21	28.13
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	216.41	64.79	31.85	0.54	0.54	7.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	429.62	101.79	57.28	0.00	0.44	25.12
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	253.18	120.87	37.16	0.41	0.00	23.28
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	131.24	86.20	31.45	0.78	0.39	18.25
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	206.63	60.35	43.79	0.00	0.18	15.82
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	257.43	117.02	39.01	0.00	0.00	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	249.35	100.16	44.15	0.00	0.23	28.35
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	181.75	83.63	35.21	0.00	0.26	16.31
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	156.35	63.12	36.53	0.00	0.29	17.24
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	88.30	26.03	21.38	0.00	0.00	8.37
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	340.11	56.34	29.61	2.47	0.41	21.80
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	189.08	23.64	54.94	0.00	0.31	6.75
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	291.44	75.53	43.10	0.00	0.00	23.04
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	242.33	64.60	37.91	0.00	0.00	28.51
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	315.32	75.82	46.70	0.00	0.24	32.50
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	225.86	45.66	53.46	0.00	0.22	12.92
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	225.81	30.69	40.69	0.00	0.00	10.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	167.24	42.74	57.60	0.00	0.00	13.01
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	240.31	61.40	54.24	0.00	0.00	12.05
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	77.20	56.26	33.15	0.44	0.00	10.03
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	59.98	41.24	41.24	0.00	0.00	11.25
adenocarcinoma cell line:IM95m	10796-110I4	108.57	24.96	54.64	0.00	0.47	10.36
adipose tissue, adult, pool1	10010-101C1	352.12	33.66	39.56	0.16	0.16	10.08
adipose, donor1	10184-103D4	480.27	250.40	88.55	0.00	3.52	19.35
adipose, donor2	10185-103D5	728.72	172.75	170.72	0.00	3.24	73.80
adipose, donor3	10186-103D6	408.70	138.87	72.16	0.00	1.91	34.58
adipose, donor4	10187-103D7	386.57	90.14	57.21	0.00	0.87	13.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	116.47	47.98	47.50	0.00	0.16	13.41
adrenal gland, adult, pool1	10081-102A9	363.77	14.55	65.48	0.00	7.28	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	141.41	26.55	43.76	0.00	0.13	8.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	233.32	67.53	50.02	0.00	0.00	13.22
amniotic membrane cells, donor1	12235-129G3	292.13	16.23	67.47	0.23	0.00	4.41
amniotic membrane cells, donor2	12236-129G4	432.77	33.81	61.53	0.00	1.01	6.09
amniotic membrane cells, donor3	12237-129G5	337.91	8.84	68.94	0.59	0.29	3.24
amygdala - adult, donor10196	10167-103B5	174.31	34.39	18.97	0.00	1.19	2.37
amygdala, adult, donor10252	10151-102I7	224.26	19.67	17.24	0.00	0.00	3.85
amygdala, newborn, donor10223	10360-105E9	105.22	17.43	11.94	0.65	0.32	3.55
anaplastic carcinoma cell line:8305C	10428-106D5	140.19	31.83	25.34	0.13	0.00	6.24
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	211.80	37.51	52.07	2.21	0.88	10.81
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	166.02	32.74	68.48	1.00	0.33	10.36
aorta, adult, pool1	10052-101G7	133.57	40.21	44.13	0.20	0.78	10.40
appendix, adult	10189-103D9	280.22	34.93	44.25	0.39	0.00	6.99
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	130.01	76.70	39.90	0.00	0.34	15.82
artery, adult	10190-103E1	512.23	101.90	69.29	0.00	0.00	20.38
astrocytoma cell line:TM-31	10425-106D2	398.96	124.01	36.80	0.43	0.14	25.35
b cell line:RPMI1788	10427-106D4	73.90	42.83	27.06	0.00	0.30	10.86
basal cell carcinoma cell line:TE 354.T	10702-109G9	997.14	48.28	33.57	1.39	0.55	19.98
bile duct carcinoma cell line:HuCCT1	10432-106D9	390.48	41.68	38.80	0.30	0.20	12.40
bile duct carcinoma cell line:TFK-1	10496-107C1	206.54	8.87	28.12	0.00	0.00	3.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	93.95	31.88	40.27	0.56	0.00	5.03
bladder, adult, pool1	10011-101C2	203.92	59.64	33.35	0.00	0.22	12.06
blood, adult, pool1	10053-101G8	644.46	35.43	183.81	0.00	2.21	11.07
bone marrow stromal cell line:StromaNKtert	10686-109F2	101.91	28.26	17.13	0.00	0.00	9.42
bone marrow, adult	10192-103E3	311.77	31.04	35.09	0.67	0.00	12.15
brain, adult, donor1	10084-102B3	311.62	24.60	24.60	0.00	0.00	5.13
brain, adult, pool1	10012-101C3	212.58	24.50	19.49	0.00	0.11	8.35
brain, fetal, pool1	10085-102B4	85.48	45.41	21.37	0.00	0.00	13.36
breast carcinoma cell line:MCF7	10482-107A5	240.17	55.83	73.34	0.00	0.33	10.57
breast carcinoma cell line:MDA-MB-453	10419-106C5	129.07	29.58	36.45	0.00	0.25	5.62
breast, adult, donor1	10080-102A8	608.00	30.31	70.71	0.00	0.63	15.15
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	279.48	52.34	70.51	0.00	0.51	24.26
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	166.98	47.93	69.27	0.00	0.93	12.06
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	552.99	83.34	103.83	0.00	0.23	23.48
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	513.22	44.54	147.43	0.00	0.48	17.19
carcinoid cell line:NCI-H1770	10703-109H1	126.00	60.65	44.67	0.00	1.41	13.63
carcinoid cell line:NCI-H727	10735-110B6	71.64	20.34	22.20	0.00	0.00	6.56
carcinoid cell line:SK-PN-DW	10719-109I8	190.14	76.37	39.30	0.00	0.32	12.36
carcinosarcoma cell line:JHUCS-1	10642-109A3	144.27	48.18	44.72	0.00	0.27	10.11
caudate nucleus - adult, donor10196	10177-103C6	280.92	33.39	28.78	0.00	0.00	11.51
caudate nucleus, adult, donor10252	10164-103B2	208.99	25.77	25.10	0.00	0.00	5.69
caudate nucleus, adult, donor10258	10379-105H1	356.09	33.62	32.09	0.00	0.00	9.17
caudate nucleus, newborn, donor10223	10354-105E3	173.59	16.85	17.95	0.37	0.37	3.30
cerebellum - adult, donor10196	10173-103C2	171.88	20.39	32.05	0.00	0.00	11.65
cerebellum, adult, donor10252	10166-103B4	280.55	16.44	21.78	0.43	0.00	6.41
cerebellum, adult, pool1	10083-102B2	129.01	17.94	23.80	0.00	0.00	3.79
cerebellum, newborn, donor10223	10357-105E6	72.23	10.79	10.79	0.00	0.00	3.32
cerebral meninges, adult	10188-103D8	167.42	22.94	31.01	0.00	0.25	4.29
cerebrospinal fluid, donor2	10294-104G6	236.08	22.66	41.66	0.73	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	489.29	56.08	104.53	0.00	0.14	20.56
cervical cancer cell line:ME-180	10553-107I4	209.30	26.68	24.19	0.00	0.17	9.94
cervix, adult, pool1	10013-101C4	204.52	49.77	40.53	0.00	0.21	11.13
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	291.91	58.52	37.34	0.14	0.28	13.79
chondrosarcoma cell line:SW 1353	10700-109G7	54.86	10.45	11.76	0.00	0.00	3.92
choriocarcinoma cell line:BeWo	10423-106C9	570.92	64.00	54.56	0.12	0.12	22.25
choriocarcinoma cell line:SCH	10785-110H2	370.13	31.30	30.19	0.00	0.12	9.12
choriocarcinoma cell line:T3M-3	10618-108G6	281.77	18.03	46.01	0.00	0.24	7.83
chorionic membrane cells, donor1	12238-129G6	398.32	14.53	45.59	0.28	0.00	3.13
chorionic membrane cells, donor2	12239-129G7	447.04	34.60	27.84	0.40	0.10	8.75
chorionic membrane cells, donor3	12240-129G8	430.25	16.48	49.45	0.55	1.10	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	195.90	104.01	8.08	0.00	1.01	19.19
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	419.93	89.90	68.58	0.38	0.38	26.89
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	180.56	54.70	60.61	0.00	0.21	18.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	561.62	73.96	112.48	0.00	0.51	22.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	576.88	67.97	110.30	0.00	0.24	20.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	508.01	76.56	90.81	0.00	0.20	17.10
chronic myelogenous leukemia cell line:K562	10454-106G4	552.10	83.33	89.51	0.00	0.59	25.03
chronic myelogenous leukemia cell line:KU812	10409-106B4	268.44	95.13	45.35	0.52	0.26	22.67
clear cell carcinoma cell line:JHOC-5	10638-108I8	315.67	106.52	72.92	0.23	0.23	25.14
clear cell carcinoma cell line:TEN	10636-108I6	313.35	28.46	38.87	0.00	0.00	7.98
colon carcinoma cell line:CACO-2	10513-107D9	573.10	70.84	47.41	0.37	0.00	20.68
colon carcinoma cell line:COLO-320	10420-106C6	168.76	69.17	38.77	0.38	0.00	17.48
colon, adult, donor1	10082-102B1	314.17	30.94	55.93	1.19	0.00	8.33
colon, adult, pool1	10014-101C5	176.73	31.49	31.49	0.00	0.35	4.82
colon, fetal, donor1	10070-101I7	461.02	32.75	66.12	0.00	3.71	13.60
common myeloid progenitor CMP, donor1	12130-128D6	45.84	32.08	18.33	0.00	0.00	22.92
common myeloid progenitor CMP, donor2	12134-128E1	175.26	250.37	50.07	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	126.21	23.80	19.12	0.42	0.42	10.20
cord blood derived cell line:COBL-a 24h infection	10453-106G3	119.99	41.20	16.00	0.00	0.00	9.06
cord blood derived cell line:COBL-a untreated	10449-106F8	133.82	47.24	25.66	0.14	0.14	14.10
corpus callosum, adult, pool1	10042-101F6	404.33	33.50	29.74	0.11	0.11	10.72
cruciate ligament, donor2	10295-104G7	149.94	17.83	36.47	0.00	0.00	6.48
diaphragm, fetal, donor1	10069-101I6	301.76	47.35	56.18	0.00	0.00	4.82
diencephalon, adult	10193-103E4	199.19	23.04	19.20	0.00	0.00	6.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	206.65	149.48	46.15	0.00	0.00	26.41
ductal cell carcinoma cell line:KLM-1	10438-106E6	187.71	27.44	44.88	0.00	0.51	11.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	264.79	48.87	40.92	0.48	0.00	8.18
ductus deferens, adult	10196-103E7	244.19	37.38	62.79	0.00	1.50	5.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	159.87	23.04	60.49	0.00	1.44	12.96
duodenum, fetal, donor1, tech_rep2	10071-101I8	164.79	45.61	33.84	0.00	0.00	5.89
dura mater, adult, donor1	10041-101F5	176.82	55.00	42.86	0.17	0.08	13.05
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	257.38	41.31	35.53	0.22	0.22	8.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	378.29	70.50	60.76	0.00	0.29	18.48
embryonic pancreas cell line:1B2C6	10604-108F1	136.27	13.57	25.28	0.62	0.62	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	152.57	28.76	22.40	0.00	0.00	8.48
embryonic pancreas cell line:1C3IKEI	10606-108F3	143.88	21.61	21.61	0.00	0.00	5.87
embryonic pancreas cell line:2C6	10603-108E9	116.90	18.39	31.52	0.00	0.00	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	257.77	74.75	52.63	0.00	0.00	18.10
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	112.18	24.10	36.97	0.00	0.00	9.79
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	330.31	29.75	60.63	0.00	0.16	10.45
epidermoid carcinoma cell line:A431	10426-106D3	211.87	39.46	44.24	0.22	0.22	11.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	185.55	36.63	32.45	0.33	0.22	11.11
epididymis, adult	10197-103E8	255.99	52.96	54.00	0.00	0.84	13.19
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	75.04	34.42	24.84	0.00	0.00	10.11
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	82.19	14.16	17.30	0.00	0.00	7.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	778.83	52.68	95.14	0.26	0.66	17.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	629.99	46.16	76.57	0.39	0.30	16.14
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	727.74	47.39	88.95	0.45	0.34	18.93
esophagus, adult, pool1	10015-101C6	243.47	37.59	40.14	0.00	0.11	10.09
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	141.89	88.04	43.96	0.13	0.00	17.41
eye - muscle inferior rectus, donor1	10272-104E2	210.07	12.07	26.56	0.00	2.41	12.07
eye - muscle lateral, donor2	10298-104H1	246.19	29.46	29.46	0.00	2.10	8.42
eye - muscle medial, donor2	10299-104H2	138.40	10.42	14.88	0.00	0.00	5.95
eye - muscle superior, donor2	10297-104G9	189.17	29.81	25.22	0.00	1.15	10.32
eye - vitreous humor, donor1	10268-104D7	80.16	18.95	21.86	0.00	0.00	11.66
eye, fetal, donor1	10054-101G9	201.35	31.02	50.08	0.00	0.25	8.14
fibrosarcoma cell line:HT-1080	10758-110E2	226.19	39.49	37.31	0.13	0.13	10.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	200.86	30.63	35.14	0.00	0.00	6.17
frontal lobe, adult, pool1	10040-101F4	177.80	24.77	19.05	0.00	0.09	6.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	318.26	30.33	66.66	0.00	0.90	14.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	153.70	46.82	29.44	0.09	0.00	17.83
gall bladder, adult	10198-103E9	135.20	27.52	36.70	0.00	0.24	6.28
gamma delta positive T cells, donor1	11937-126A2	78.38	54.76	23.62	1.07	0.00	9.13
gamma delta positive T cells, donor2	11938-126A3	128.11	55.28	31.37	0.37	1.12	14.57
gastric adenocarcinoma cell line:MKN1	10614-108G2	289.58	55.76	44.36	0.63	0.00	11.41
gastric adenocarcinoma cell line:MKN45	10612-108F9	199.99	20.70	55.32	0.00	0.19	5.80
gastric cancer cell line:AZ521	10549-107H9	213.63	73.78	41.15	0.00	0.33	21.15
gastric cancer cell line:GSS	10560-108A2	140.03	27.46	56.74	0.00	0.00	9.15
gastrointestinal carcinoma cell line:ECC12	10615-108G3	157.86	37.47	39.29	0.23	0.00	8.68
giant cell carcinoma cell line:LU65	10487-107B1	267.35	30.64	46.93	0.00	0.00	10.44
giant cell carcinoma cell line:Lu99B	10433-106E1	341.78	46.89	71.66	0.00	0.14	14.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	172.35	17.21	34.17	0.00	0.25	3.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	386.64	44.44	44.97	0.11	0.84	15.62
glioblastoma cell line:A172, tech_rep2	10444-106F3	344.36	45.08	44.38	0.14	0.56	15.03
glioblastoma cell line:T98G	10485-107A8	339.95	76.93	60.48	0.11	0.33	18.43
glioma cell line:GI-1	10413-106B8	298.15	72.63	47.15	0.29	0.29	11.13
globus pallidus - adult, donor10196	10175-103C4	245.64	18.95	32.80	0.00	3.64	3.64
globus pallidus, adult, donor10252	10161-103A8	213.34	18.55	21.72	0.00	0.98	4.39
globus pallidus, adult, donor10258	10367-105F7	235.50	20.54	23.28	0.00	1.37	5.48
globus pallidus, newborn, donor10223	10364-105F4	151.88	22.38	16.52	0.00	0.00	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	17.13	24.47	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	174.85	10.93	0.00	0.00	32.79
granulocyte macrophage progenitor, donor3	12139-128E6	198.61	229.97	52.27	5.23	0.00	36.59
granulosa cell tumor cell line:KGN	10624-108H3	99.84	34.24	15.04	0.00	0.32	7.36
hIPS +CCl2, biol_rep1	14383-156B9	587.67	98.71	49.58	0.00	0.46	17.91
hIPS +CCl2, biol_rep2	14384-156C1	615.02	106.54	56.70	0.00	0.46	18.75
hIPS +CCl2, biol_rep3	14385-156C2	644.09	87.60	53.46	0.00	0.00	18.68
hIPS, biol_rep1	14380-156B6	672.65	56.05	50.31	0.00	2.87	4.31
hIPS, biol_rep2	14381-156B7	692.04	82.99	62.41	0.00	1.37	13.72
hIPS, biol_rep3	14382-156B8	372.97	38.62	34.21	0.00	3.31	3.31
hairy cell leukemia cell line:Mo	10712-109I1	201.14	79.59	49.71	0.29	0.86	23.27
heart - mitral valve, adult	10205-103F7	239.47	49.63	38.27	0.30	0.30	9.57
heart - pulmonic valve, adult	10206-103F8	202.90	57.52	32.42	0.00	0.00	11.77
heart - tricuspid valve, adult	10207-103F9	350.54	16.65	34.14	0.00	5.83	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	566.67	58.56	66.52	0.00	0.61	14.28
heart, adult, diseased, donor1	10051-101G6	893.40	86.02	79.20	0.00	0.43	20.87
heart, adult, pool1	10016-101C7	313.69	51.74	31.51	0.00	1.84	8.74
heart, fetal, pool1	10046-101G1	274.36	118.80	38.40	0.00	0.10	22.69
hepatic mesenchymal tumor cell line:LI90	10778-110G4	526.34	37.64	45.35	3.09	0.00	14.81
hepatoblastoma cell line:HuH-6	10633-108I3	244.97	23.78	42.81	1.19	1.19	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	340.11	58.45	41.10	0.11	0.55	11.16
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	350.89	69.67	41.27	0.00	0.24	13.47
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	360.25	75.39	45.27	0.00	0.20	15.97
hepatoma cell line:Li-7	10484-107A7	376.02	42.48	24.80	0.00	0.22	9.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	116.88	82.81	24.32	0.40	0.10	13.77
hippocampus - adult, donor10196	10169-103B7	222.39	23.66	31.23	0.00	1.89	10.41
hippocampus, adult, donor10252	10153-102I9	353.30	18.37	19.39	0.20	0.82	6.74
hippocampus, adult, donor10258	10374-105G5	208.64	19.92	21.91	0.00	0.50	3.49
hippocampus, newborn, donor10223	10363-105F3	112.44	16.57	12.69	0.00	1.41	4.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	983.26	230.71	93.99	0.00	0.00	26.24
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	920.12	133.13	80.31	0.00	1.18	25.92
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	946.52	152.34	73.88	0.00	1.27	34.53
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	455.60	128.56	115.59	0.00	2.82	26.50
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	515.91	137.88	111.55	0.00	1.03	30.21
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	556.89	193.60	105.53	0.00	0.76	32.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	478.22	184.22	87.59	0.00	0.29	54.30
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	488.38	212.20	109.65	0.00	0.86	68.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	488.81	146.81	81.33	0.00	0.42	49.63
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	536.81	223.30	76.25	0.00	0.24	66.78
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	623.58	235.93	83.25	0.00	1.77	68.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	537.97	232.29	67.33	0.00	0.67	65.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	934.68	139.90	84.50	0.00	0.47	29.11
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1080.85	150.83	84.01	0.00	1.47	28.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1521.21	240.88	88.15	0.00	1.75	51.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	867.12	144.33	137.84	0.00	1.53	27.68
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	821.56	131.26	134.31	0.00	1.31	23.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	696.17	166.92	120.44	0.00	1.50	22.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	871.12	266.01	155.05	0.00	1.70	87.41
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1080.41	323.76	163.70	0.00	5.91	113.22
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	844.80	269.38	140.33	0.00	1.57	83.01
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	576.46	200.21	83.61	0.00	1.47	50.30
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	678.16	239.21	96.96	0.00	0.58	58.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	548.22	167.40	84.89	0.00	2.09	45.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	673.39	139.67	67.25	0.18	1.11	30.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	625.06	133.51	57.34	0.00	0.57	30.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	735.37	191.09	62.06	0.00	0.41	36.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	778.80	111.96	94.01	0.00	1.06	25.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	770.95	108.96	95.34	0.00	0.63	24.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	941.15	123.47	95.93	0.00	0.30	26.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	626.75	161.86	107.56	0.00	0.00	40.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	698.04	162.06	130.18	0.00	2.66	57.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	343.75	122.37	72.09	0.00	1.03	31.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	506.44	154.41	68.51	0.00	1.79	33.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	608.81	174.92	81.78	0.00	0.00	57.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	583.73	144.50	72.59	0.00	2.02	37.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	718.24	139.83	68.10	0.24	0.24	27.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	775.89	166.23	58.83	0.00	0.45	33.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	763.42	148.29	67.81	0.00	0.49	26.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	720.65	128.05	104.52	0.00	2.14	25.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	839.34	816.56	149.65	0.00	3.25	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	825.04	172.42	104.25	0.00	0.33	31.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	716.96	221.66	132.99	0.00	0.55	50.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	669.12	216.77	109.65	0.00	1.81	55.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	798.58	219.57	96.44	0.00	0.36	72.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	733.93	169.46	62.06	0.00	0.00	34.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	611.58	216.27	69.61	0.00	1.22	57.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	569.23	134.70	63.31	0.00	1.08	36.64
immature langerhans cells, donor1	11904-125F5	22.76	9.20	12.35	0.48	0.00	2.18
immature langerhans cells, donor2	11905-125F6	46.74	10.30	10.30	2.38	0.00	0.79
insula, adult, pool1	10039-101F3	184.06	33.50	20.06	0.00	0.00	10.50
keratoacanthoma cell line:HKA-1	10791-110H8	188.59	36.42	49.10	0.00	0.98	15.61
kidney, adult, pool1	10017-101C8	301.38	64.08	43.56	0.00	0.60	17.92
kidney, fetal, pool1	10045-101F9	282.17	99.24	51.00	0.00	0.00	29.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	152.53	38.49	24.14	0.43	0.00	7.39
large cell lung carcinoma cell line:NCI-H460	10839-111E2	555.73	58.89	71.75	0.28	0.55	9.95
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	284.61	17.43	20.55	0.37	0.18	6.06
left atrium, adult, donor1	10079-102A7	286.59	63.20	44.13	0.00	1.09	7.08
left ventricle, adult, donor1	10078-102A6	476.33	54.11	74.84	0.00	1.01	12.14
leiomyoblastoma cell line:G-402	10721-110A1	221.35	41.59	61.84	0.00	0.82	14.23
leiomyoma cell line:10964C	10569-108B2	491.09	52.81	43.47	0.00	0.00	11.14
leiomyoma cell line:15242A	10570-108B3	767.39	51.63	38.59	0.54	1.63	19.57
leiomyoma cell line:15425	10571-108B4	466.69	45.41	47.11	0.00	0.00	11.41
leiomyosarcoma cell line:Hs 5.T	10722-110A2	241.28	114.29	31.75	6.35	0.00	19.05
lens epithelial cell line:SRA 01/04	10647-109A8	126.51	26.14	27.18	0.00	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	335.05	82.64	59.62	0.24	0.35	12.87
liposarcoma cell line:KMLS-1	10782-110G8	244.94	31.40	35.93	0.00	0.00	10.15
liposarcoma cell line:SW 872	10726-110A6	215.66	52.15	25.71	0.73	0.12	11.94
liver, adult, pool1	10018-101C9	631.07	33.06	74.87	0.00	0.32	11.02
liver, fetal, pool1	10086-102B5	385.69	20.70	65.85	0.00	0.00	7.53
locus coeruleus - adult, donor10196	10182-103D2	307.40	15.17	31.35	0.15	4.08	5.10
locus coeruleus, adult, donor10252	10165-103B3	284.58	20.12	23.81	0.00	0.18	4.24
locus coeruleus, adult, donor10258	10375-105G6	480.20	26.80	52.20	0.00	0.00	9.87
locus coeruleus, newborn, donor10223	10362-105F2	235.97	26.92	19.35	0.00	1.68	7.15
lung adenocarcinoma cell line:A549	10499-107C4	147.67	25.88	27.96	0.00	0.28	6.92
lung adenocarcinoma cell line:PC-14	10408-106B3	79.97	15.17	32.40	0.00	0.00	4.83
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.25	12.39	33.74	0.00	0.00	5.01
lung, adult, pool1	10019-101D1	226.80	34.49	32.37	0.12	0.12	7.91
lung, fetal, donor1	10068-101I5	471.78	68.50	54.80	0.29	0.57	10.56
lung, right lower lobe, adult, donor1	10075-102A3	227.73	24.74	58.19	0.00	0.46	5.04
lymph node, adult, donor1	10077-102A5	176.09	31.72	48.28	0.00	0.47	11.83
lymphangiectasia cell line:DS-1	10727-110A7	111.12	27.18	70.14	0.22	0.00	7.23
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	155.00	64.45	26.41	0.30	0.15	13.58
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	175.85	11.04	21.24	0.00	0.00	4.25
mature adipocyte, donor1	12231-129F8	587.40	46.62	83.91	0.00	0.00	11.54
mature adipocyte, donor2	12232-129F9	631.30	44.20	77.82	0.21	0.62	14.32
mature adipocyte, donor3	12233-129G1	631.30	55.71	107.86	0.00	0.71	15.17
mature adipocyte, donor4	12234-129G2	873.88	63.70	97.39	0.26	0.53	11.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	327.13	37.41	88.63	0.00	0.00	9.77
medial frontal gyrus - adult, donor10196	10170-103B8	133.11	25.94	16.92	0.00	0.00	9.02
medial frontal gyrus, adult, donor10252	10150-102I6	283.95	13.61	18.76	0.18	0.18	4.23
medial frontal gyrus, adult, donor10258	10368-105F8	212.85	16.84	22.87	0.00	0.32	5.40
medial frontal gyrus, newborn, donor10223	10352-105E1	67.81	31.99	11.09	0.85	0.00	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	176.01	27.00	23.63	0.17	0.51	4.89
medial temporal gyrus, adult, donor10252	10156-103A3	259.13	15.28	20.80	0.00	0.21	3.18
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	90.53	11.56	13.48	0.00	1.93	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	73.58	12.20	9.69	0.00	0.00	3.59
medulla oblongata - adult, donor10196	10174-103C3	273.87	28.56	27.26	0.00	1.30	5.84
medulla oblongata, adult, donor10252	10155-103A2	239.02	20.43	29.88	0.15	1.24	3.87
medulla oblongata, adult, pool1	10038-101F2	251.49	32.57	30.20	0.00	0.33	9.14
medulla oblongata, newborn, donor10223	10361-105F1	312.12	16.66	29.51	0.00	0.69	4.51
medulloblastoma cell line:D283 Med	10838-111E1	1090.01	139.49	104.51	0.00	0.22	21.26
medulloblastoma cell line:ONS-76	10759-110E3	168.61	27.27	49.64	0.00	0.24	7.70
melanoma cell line:COLO 679	10514-107E1	206.85	19.69	48.30	0.14	0.00	5.61
melanoma cell line:G-361	10465-106H6	127.04	25.25	44.52	0.00	0.27	11.40
meningioma cell line:HKBMM	10691-109F7	259.06	38.35	28.04	0.00	0.18	10.85
merkel cell carcinoma cell line:MKL-1	10843-111E6	74.90	35.25	29.96	0.00	1.76	8.81
merkel cell carcinoma cell line:MS-1	10844-111E7	54.70	30.59	19.96	0.00	0.00	8.55
mesenchymal precursor cell - adipose, donor1	11747-123G1	330.80	63.21	63.98	0.15	0.61	10.43
mesenchymal precursor cell - adipose, donor2	11748-123G2	256.67	57.81	47.08	0.18	0.00	8.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	340.81	65.43	52.18	0.00	0.00	7.04
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	128.82	46.78	31.61	0.00	0.14	5.62
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	153.28	53.73	38.13	0.00	0.39	7.13
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	219.33	30.54	54.14	0.00	0.00	9.02
mesenchymal precursor cell - cardiac, donor1	11752-123G6	213.86	49.60	42.91	0.00	0.34	5.15
mesenchymal precursor cell - cardiac, donor2	11753-123G7	207.26	39.68	43.36	0.35	0.12	6.33
mesenchymal precursor cell - cardiac, donor3	11754-123G8	253.47	57.56	44.96	0.13	0.27	9.55
mesenchymal precursor cell - cardiac, donor4	11755-123G9	197.43	34.44	39.84	0.14	0.14	7.83
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	267.03	40.26	28.45	1.00	0.43	5.83
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	172.25	34.25	32.61	0.00	0.00	4.94
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	272.32	42.90	35.98	0.55	0.14	8.03
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	305.80	38.05	50.27	0.35	0.00	13.27
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	506.33	43.28	48.80	1.22	0.20	8.57
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	383.90	25.16	24.80	2.52	0.72	6.83
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	178.66	43.66	28.97	0.41	0.10	6.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	427.03	31.23	24.40	2.28	0.91	8.66
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	406.97	40.70	46.99	1.26	0.00	7.55
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	169.61	31.83	32.73	0.00	0.15	4.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	280.80	49.10	30.37	0.18	0.18	7.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	182.61	39.39	27.24	0.00	0.74	5.89
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	345.68	33.19	20.32	0.29	0.57	9.44
mesenchymal stem cell line:Hu5/E18	10568-108B1	399.96	47.57	50.52	0.42	0.00	16.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	215.55	44.75	47.49	0.46	0.00	4.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	220.49	49.11	41.95	0.00	0.26	9.98
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	221.18	43.45	37.69	0.00	0.00	9.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	227.98	40.05	43.75	0.00	0.00	8.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	213.70	51.07	41.66	0.00	0.47	9.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	245.72	44.68	43.66	0.34	0.00	11.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	227.92	47.16	35.76	0.00	0.00	8.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	246.06	51.90	41.24	0.00	0.00	8.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	193.21	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	272.27	57.68	50.18	0.00	0.00	11.25
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	250.54	47.52	42.84	0.00	0.00	11.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	260.06	47.11	55.76	0.00	0.24	10.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	217.07	50.60	40.33	0.00	0.00	7.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	238.99	45.31	43.64	0.00	0.00	11.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	259.55	42.98	45.85	0.00	0.00	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	277.92	42.96	53.69	0.00	0.43	9.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	347.27	79.30	54.69	0.00	2.73	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	294.40	56.81	61.98	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	302.38	50.99	58.14	0.00	0.32	8.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	330.28	65.47	50.92	0.00	2.91	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	338.51	47.44	63.97	0.53	0.00	14.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	309.94	58.06	62.15	0.00	0.00	12.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	313.31	46.26	45.87	0.00	0.39	7.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	356.78	56.67	52.47	0.00	0.00	14.69
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	361.62	35.76	52.65	0.00	0.00	15.90
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	390.91	61.97	66.74	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	333.25	42.69	50.99	0.00	0.00	8.30
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	375.29	57.27	82.86	0.00	1.22	9.75
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	324.63	54.10	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	414.23	53.20	59.54	0.00	0.00	12.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	488.04	46.91	67.26	0.34	1.72	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	593.18	75.22	83.82	0.00	2.15	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	498.97	55.89	83.83	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	867.86	58.55	86.10	0.00	0.00	20.66
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	782.34	52.56	68.05	0.00	1.22	12.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	889.77	54.82	88.18	0.00	0.79	11.12
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1184.36	49.52	85.48	0.00	1.18	8.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1184.48	41.77	97.88	0.00	0.94	9.35
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1216.37	45.45	117.63	0.00	2.67	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1361.26	52.04	87.52	0.00	0.00	14.19
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	1551.07	82.18	102.72	0.00	0.00	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1324.47	46.81	104.64	0.00	2.07	15.14
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1085.61	57.40	83.13	0.99	1.98	16.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	810.85	41.50	66.17	0.00	0.00	16.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1002.44	55.97	80.14	0.00	0.64	13.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	734.64	56.82	82.61	1.21	0.81	14.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	822.08	47.97	102.49	0.00	0.00	19.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	724.76	51.95	79.82	1.27	2.53	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	509.79	46.12	66.76	0.00	1.82	9.71
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	709.48	63.27	122.01	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	523.86	38.71	72.48	0.00	2.47	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	435.94	51.99	54.77	0.00	0.60	10.52
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	454.94	45.43	59.38	0.00	0.00	7.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	447.18	35.65	50.93	0.00	1.02	9.17
mesodermal tumor cell line:HIRS-BM	10696-109G3	46.42	23.21	5.42	0.00	0.00	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	203.40	54.34	39.22	0.00	0.47	15.59
mesothelioma cell line:ACC-MESO-4	10494-107B8	418.40	34.98	57.46	0.23	1.16	13.21
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	538.47	25.64	34.19	0.00	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	502.04	42.02	36.48	0.10	0.21	10.17
mesothelioma cell line:Mero-25	10850-111F4	415.78	50.61	37.67	0.00	0.23	11.57
mesothelioma cell line:Mero-41	10851-111F5	535.89	61.61	88.50	0.00	0.49	14.91
mesothelioma cell line:Mero-48a	10852-111F6	207.26	36.31	44.73	0.00	0.22	7.53
mesothelioma cell line:Mero-82	10853-111F7	314.05	34.95	29.96	0.00	0.53	8.94
mesothelioma cell line:Mero-83	10854-111F8	633.22	46.64	36.94	0.00	0.68	12.09
mesothelioma cell line:Mero-84	10855-111F9	399.38	47.52	50.05	0.00	1.01	11.63
mesothelioma cell line:Mero-95	10856-111G1	507.05	67.70	75.16	0.00	0.83	16.77
mesothelioma cell line:NCI-H2052	10847-111F1	64.11	7.79	5.30	0.00	0.00	1.33
mesothelioma cell line:NCI-H226	10846-111E9	786.05	50.50	42.90	0.00	0.18	17.74
mesothelioma cell line:NCI-H2452	10848-111F2	450.80	71.06	58.08	0.00	0.34	19.82
mesothelioma cell line:NCI-H28	10845-111E8	389.08	84.48	62.60	0.00	0.00	26.21
mesothelioma cell line:No36	10857-111G2	441.35	40.45	54.15	0.00	0.33	10.11
mesothelioma cell line:ONE58	10858-111G3	333.27	46.60	29.53	0.00	0.00	13.28
migratory langerhans cells, donor1	11901-125F2	164.29	19.58	25.53	0.00	0.00	9.21
migratory langerhans cells, donor2	11902-125F3	59.47	5.25	18.81	0.00	0.00	2.56
migratory langerhans cells, donor3	11903-125F4	100.15	21.36	25.49	0.18	0.00	4.49
mixed mullerian tumor cell line:HTMMT	10689-109F5	207.31	26.12	26.77	0.00	1.31	8.49
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	310.49	76.72	39.21	0.00	0.85	20.98
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	243.03	19.12	40.77	0.23	0.00	7.37
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	222.45	51.38	49.10	1.52	0.00	18.08
myelodysplastic syndrome cell line:SKM-1	10772-110F7	418.55	121.78	65.23	0.00	0.55	43.43
myeloma cell line:PCM6	10474-106I6	85.00	8.70	32.42	0.00	0.00	3.95
myxofibrosarcoma cell line:MFH-ino	10600-108E6	225.74	25.36	32.47	0.00	0.00	5.58
myxofibrosarcoma cell line:NMFH-1	10684-109E9	126.31	16.87	44.33	0.00	0.20	5.69
nasal epithelial cells, donor1, tech_rep1	12226-129F3	167.36	15.15	45.35	0.00	0.00	7.69
nasal epithelial cells, donor1, tech_rep2	12226-129F3	171.28	18.90	47.14	0.00	0.00	5.74
nasal epithelial cells, donor2	12227-129F4	136.89	34.22	25.94	0.00	0.00	9.38
neuroblastoma cell line:CHP-134	10508-107D4	98.47	93.40	22.09	0.00	0.00	16.56
neuroblastoma cell line:NB-1	10539-107G8	387.27	226.00	101.03	0.00	0.37	51.82
neuroblastoma cell line:NBsusSR	10607-108F4	207.51	78.66	25.52	0.00	0.21	19.19
neuroblastoma cell line:NH-12	10555-107I6	180.57	82.93	43.79	0.37	0.19	12.67
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	207.10	93.47	41.28	0.00	0.24	18.03
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	295.06	60.18	42.13	0.00	1.27	10.93
neuroectodermal tumor cell line:TASK1	10774-110F9	292.83	123.37	58.37	0.20	0.00	23.95
neuroepithelioma cell line:SK-N-MC	10728-110A8	47.68	26.70	13.35	0.00	0.64	5.09
neurofibroma cell line:Hs 53.T	10729-110A9	346.28	40.46	38.86	0.53	0.27	10.11
neutrophil PMN, donor1	12133-128D9	44.62	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	28.41	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	293.93	157.11	44.82	0.17	0.34	37.71
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	264.17	64.84	117.67	0.00	0.00	21.61
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	282.13	60.92	45.85	0.00	0.96	12.82
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	702.11	83.82	38.10	0.26	0.53	19.18
nucleus accumbens, adult, pool1	10037-101F1	198.54	30.18	23.43	0.00	0.09	9.19
occipital cortex - adult, donor10196	10172-103C1	173.07	22.66	22.66	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	286.34	17.44	18.25	0.00	1.07	3.76
occipital cortex, newborn, donor10223	10355-105E4	88.80	21.47	8.01	0.36	0.00	5.46
occipital lobe, adult, donor1	10076-102A4	258.99	19.42	35.42	0.00	0.52	6.04
occipital lobe, fetal, donor1	10073-102A1	36.90	16.31	20.60	0.00	0.43	3.86
occipital pole, adult, pool1	10036-101E9	216.26	25.62	19.47	0.00	0.16	7.96
olfactory region, adult	10195-103E6	221.05	17.96	23.12	0.00	0.19	4.97
optic nerve, donor1	10277-104E7	102.05	14.01	20.01	0.00	0.00	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	109.58	19.25	24.95	0.00	0.11	4.44
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	609.03	106.47	62.10	0.00	0.41	33.80
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	175.25	29.80	25.40	0.17	0.34	6.26
oral squamous cell carcinoma cell line:SAS	10544-107H4	211.27	63.65	56.60	0.35	0.23	9.13
osteoclastoma cell line:Hs 706.T	10704-109H2	122.88	19.40	34.39	0.00	0.00	5.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.01	41.11	17.75	0.00	0.00	7.47
osteosarcoma cell line:HS-Os-1	10558-107I9	221.39	63.83	28.84	0.21	0.00	12.51
ovary, adult, pool1	10020-101D2	193.40	39.05	37.30	0.00	0.09	8.65
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	118.42	25.85	24.20	0.37	0.00	6.23
pancreas, adult, donor1	10049-101G4	189.07	20.69	106.29	0.00	0.94	9.41
pancreatic carcinoma cell line:NOR-P1	10698-109G5	265.28	25.16	28.79	0.00	0.28	6.71
papillary adenocarcinoma cell line:8505C	10437-106E5	239.69	40.71	30.83	0.00	0.00	11.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	167.07	19.70	29.14	0.17	0.17	4.47
paracentral gyrus, adult, pool1	10035-101E8	166.48	24.89	18.40	0.00	0.00	8.33
parietal cortex, adult, donor10258	10373-105G4	220.20	27.89	23.49	0.00	0.73	2.94
parietal lobe - adult, donor10196	10171-103B9	141.07	23.51	16.93	0.00	0.00	3.76
parietal lobe, adult, donor10252	10157-103A4	247.41	13.97	19.38	0.00	0.00	4.85
parietal lobe, adult, pool1	10034-101E7	163.46	23.18	19.12	0.00	0.00	6.34
parietal lobe, fetal, donor1	10072-101I9	48.49	16.49	16.49	0.00	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	94.96	19.07	8.22	0.37	0.37	2.24
parotid gland, adult	10199-103F1	172.05	20.35	61.67	0.00	0.00	3.08
penis, adult	10200-103F2	298.63	46.19	39.21	0.00	0.54	9.13
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	141.31	40.91	30.87	0.19	0.00	8.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	166.24	36.57	32.78	0.00	0.15	8.74
pineal gland - adult, donor10196	10179-103C8	119.33	21.29	37.41	0.00	1.29	6.45
pineal gland, adult, donor10252	10160-103A7	154.57	21.91	40.27	0.00	0.00	7.70
pineal gland, adult, donor10258	10377-105G8	169.94	23.83	36.37	0.00	3.14	8.78
pituitary gland - adult, donor10196	10180-103C9	178.08	50.59	51.60	0.00	1.01	10.12
pituitary gland, adult, donor10252	10162-103A9	206.39	37.52	54.72	0.00	0.52	8.86
pituitary gland, adult, donor10258	10378-105G9	103.85	31.50	62.14	0.00	0.00	7.66
placenta, adult, pool1	10021-101D3	250.80	16.34	38.49	0.11	0.11	6.13
plasma cell leukemia cell line:ARH-77	10840-111E3	84.09	41.58	22.25	0.00	0.00	10.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	162.49	33.62	28.02	0.00	0.00	9.03
pons, adult, pool1	10033-101E6	127.55	20.66	19.97	0.00	0.00	5.42
postcentral gyrus, adult, pool1	10032-101E5	204.95	26.68	17.87	0.00	0.00	8.89
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	12.55	4.18	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	187.27	121.18	71.60	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	258.19	129.09	58.68	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	173.48	65.55	36.56	0.00	0.15	17.33
prostate cancer cell line:PC-3	10439-106E7	815.12	139.94	128.32	0.36	1.82	38.84
prostate, adult, pool1	10022-101D4	184.01	43.62	31.92	0.00	0.27	9.16
putamen, adult, donor10196	10176-103C5	147.78	39.66	18.89	0.24	0.24	8.50
putamen, adult, donor10252	10152-102I8	170.58	23.53	17.65	0.00	0.00	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	272.11	50.27	34.97	0.00	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	209.72	28.75	19.33	0.00	0.24	6.77
putamen, newborn, donor10223	10365-105F5	200.91	35.23	19.49	0.00	0.00	3.75
rectal cancer cell line:TT1TKB	10469-106I1	307.81	19.78	20.66	0.29	0.00	4.36
rectum, fetal, donor1	10067-101I4	219.78	52.86	73.72	0.00	0.00	15.30
renal cell carcinoma cell line:OS-RC-2	10411-106B6	158.36	34.56	54.27	0.21	0.00	12.93
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	190.12	12.84	49.71	0.41	0.41	4.97
retina, adult, pool1	10030-101E3	166.89	39.86	32.40	0.10	0.00	11.83
retinoblastoma cell line:Y79	10475-106I7	412.57	160.82	86.51	0.26	0.52	38.97
rhabdomyosarcoma cell line:KYM-1	10787-110H4	101.06	26.43	22.99	0.00	0.00	12.05
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	153.25	42.46	38.52	0.00	0.00	11.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	140.20	37.13	26.52	0.76	0.76	3.79
salivary acinar cells, donor1	11771-123I7	216.73	29.46	69.44	0.00	0.32	6.96
salivary acinar cells, donor2	11772-123I8	327.28	42.68	85.50	0.00	0.14	6.61
salivary acinar cells, donor3	11773-123I9	191.99	17.21	50.98	0.00	0.66	2.65
salivary gland, adult, pool1	10093-102C3	125.83	22.31	44.61	0.00	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	155.30	66.52	24.79	0.00	0.17	16.53
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	146.12	62.42	25.27	0.12	0.12	16.22
seminal vesicle, adult	10201-103F3	240.20	30.16	65.08	0.00	1.59	8.99
serous adenocarcinoma cell line:JHOS-2	10639-108I9	481.23	34.98	94.25	0.00	0.24	13.36
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	203.57	62.91	50.83	0.00	0.00	12.33
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	329.16	60.21	66.23	0.00	0.00	17.06
serous cystadenocarcinoma cell line:HTOA	10693-109F9	133.92	13.03	38.55	0.00	0.00	3.09
signet ring carcinoma cell line:Kato III	10436-106E4	80.91	14.48	25.86	0.00	0.00	3.65
signet ring carcinoma cell line:NUGC-4	10483-107A6	177.67	23.61	41.80	0.00	0.00	9.03
skeletal muscle - soleus muscle, donor1	10282-104F3	866.10	91.50	67.39	0.00	2.84	16.31
skeletal muscle, adult, pool1	10023-101D5	616.36	91.03	68.60	0.00	1.08	21.11
skeletal muscle, fetal, donor1	10066-101I3	734.67	80.40	118.59	0.00	1.01	26.13
skin, adult, donor1	10074-102A2	183.20	33.93	122.13	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	292.89	57.44	77.64	0.00	0.00	12.62
small cell cervical cancer cell line:HCSC-1	10800-110I8	75.71	27.68	31.02	0.00	0.00	9.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	110.32	36.25	43.50	0.00	0.00	7.56
small cell lung carcinoma cell line:DMS 144	10841-111E4	181.18	119.70	66.11	0.00	0.39	26.02
small cell lung carcinoma cell line:LK-2	10541-107H1	266.20	59.01	67.08	0.16	0.49	19.28
small cell lung carcinoma cell line:NCI-H82	10842-111E5	302.56	100.69	92.81	0.32	0.00	24.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	73.22	22.23	24.41	0.00	0.22	5.01
small intestine, adult, pool1	10024-101D6	164.35	18.04	46.58	0.12	0.48	5.02
small intestine, fetal, donor1	10064-101I1	108.60	27.52	51.35	0.00	0.25	8.85
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.62	2.56	27.18	0.00	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	133.10	54.28	32.05	0.00	0.00	10.34
somatostatinoma cell line:QGP-1	10781-110G7	43.69	7.50	47.98	0.27	0.00	1.34
spinal cord - adult, donor10196	10181-103D1	201.19	19.96	33.26	0.23	0.69	4.59
spinal cord, adult, donor10252	10159-103A6	163.62	26.81	22.08	0.39	1.18	9.07
spinal cord, adult, donor10258	10369-105F9	359.73	49.12	25.60	0.00	2.77	6.92
spinal cord, fetal, donor1	10056-101H2	155.51	34.15	31.71	0.00	0.61	7.32
spinal cord, newborn, donor10223	10359-105E8	125.82	24.80	22.50	0.00	0.46	5.05
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	175.94	25.39	34.05	0.75	0.15	7.47
spleen, adult, pool1	10025-101D7	136.46	35.57	22.47	0.00	0.11	10.13
spleen, fetal, pool1	10044-101F8	165.43	41.08	29.00	0.00	0.08	9.93
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	110.03	37.89	29.71	0.00	0.10	11.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	97.41	9.68	21.65	0.00	0.00	5.70
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	660.81	47.87	65.00	0.00	0.70	17.82
squamous cell carcinoma cell line:T3M-5	10616-108G4	355.36	17.20	32.06	0.39	0.00	5.86
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	215.33	42.21	30.05	0.00	0.45	11.48
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1302.15	41.94	85.14	0.00	0.42	18.64
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	523.76	82.08	42.73	0.00	0.00	27.50
stomach, fetal, donor1	10062-101H8	211.46	44.85	60.87	1.07	0.00	13.88
submaxillary gland, adult	10202-103F4	99.12	17.66	35.89	0.00	0.00	6.27
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	171.15	22.43	19.73	0.00	0.00	5.61
substantia nigra, adult, donor10258	10371-105G2	382.77	28.97	26.38	0.00	2.07	4.14
substantia nigra, newborn, donor10223	10358-105E7	176.64	13.42	18.37	0.00	0.00	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	344.59	106.61	54.11	0.00	0.23	31.41
temporal lobe, adult, pool1	10031-101E4	224.22	34.16	19.58	0.00	0.00	9.41
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.19	24.22	17.09	0.00	0.00	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.55	25.49	13.63	0.00	0.00	5.27
tenocyte, donor1	11763-123H8	208.76	42.24	49.57	0.00	0.00	13.61
tenocyte, donor2	11765-123I1	178.16	39.68	47.69	0.00	0.38	6.10
tenocyte, donor3	11768-123I4	203.12	48.93	44.85	0.00	0.37	10.38
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	509.20	95.18	68.32	0.00	1.36	34.50
teratocarcinoma cell line:NCR-G1	10798-110I6	904.39	83.24	88.17	0.46	0.46	23.58
teratocarcinoma cell line:PA-1	10807-111A6	291.20	66.02	48.82	0.00	0.31	17.51
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	515.41	77.82	51.79	0.00	0.13	26.28
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	229.17	85.09	36.30	0.00	0.38	13.61
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	237.87	46.68	35.55	0.00	0.00	7.96
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	317.89	149.82	50.16	0.00	0.00	72.31
testis, adult, pool1	10026-101D8	417.36	63.99	63.56	0.00	0.43	25.23
testis, adult, pool2	10096-102C6	519.20	48.27	79.39	0.00	1.35	23.91
thalamus - adult, donor10196	10168-103B6	228.53	19.87	34.22	0.00	0.00	4.42
thalamus, adult, donor10252	10154-103A1	255.37	18.13	18.44	0.00	0.63	3.59
thalamus, adult, donor10258, tech_rep1	10370-105G1	133.95	12.32	32.33	0.00	1.54	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	153.16	14.66	31.29	0.00	0.33	3.79
thalamus, newborn, donor10223	10366-105F6	116.21	8.63	9.78	0.00	1.15	8.05
throat, adult	10209-103G2	423.19	50.18	62.42	0.00	0.25	9.99
throat, fetal, donor1	10061-101H7	208.11	52.41	69.78	0.00	0.91	10.36
thymic carcinoma cell line:Ty-82	10803-111A2	206.28	81.88	42.53	0.00	0.20	22.06
thymus, adult, pool1	10027-101D9	75.75	72.97	15.11	0.10	0.00	10.04
thymus, fetal, pool1	10043-101F7	144.95	57.87	18.50	0.21	0.00	11.64
thyroid carcinoma cell line:KHM-5M	10776-110G2	220.05	45.47	43.88	0.27	0.40	12.23
thyroid carcinoma cell line:TCO-1	10783-110G9	309.14	42.75	57.13	0.14	0.56	15.37
thyroid, adult, pool1	10028-101E1	341.90	58.41	67.37	0.00	0.28	16.33
thyroid, fetal, donor1	10060-101H6	145.28	31.90	69.87	0.00	0.00	11.07
tongue epidermis (fungiform papillae), donor1	10288-104F9	132.42	40.04	43.11	0.00	0.00	0.00
tongue, adult	10203-103F5	414.92	67.21	50.00	0.00	0.70	14.42
tongue, fetal, donor1	10059-101H5	505.23	92.22	68.57	0.00	0.79	19.70
tonsil, adult, pool1	10047-101G2	194.74	35.96	46.18	0.10	0.00	11.52
trachea, adult, pool1	10029-101E2	218.81	31.49	42.29	0.16	0.08	7.77
trachea, fetal, donor1	10058-101H4	220.43	44.62	60.78	0.00	0.38	10.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	321.68	56.68	50.66	0.00	1.42	10.27
transitional-cell carcinoma cell line:5637	10418-106C4	197.26	56.23	39.31	0.51	0.10	13.17
transitional-cell carcinoma cell line:JMSU1	10492-107B6	370.09	100.75	63.30	0.31	0.47	24.29
tridermal teratoma cell line:HGRT	10694-109G1	93.22	24.73	22.83	1.90	1.90	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	104.88	31.91	30.47	0.00	0.08	6.18
umbilical cord, fetal, donor1	10057-101H3	279.59	47.99	52.16	0.00	0.00	4.17
uterus, adult, pool1	10100-102D1	270.62	46.07	37.20	0.00	0.00	7.68
uterus, fetal, donor1	10055-101H1	237.02	41.98	55.80	0.00	1.02	11.26
vagina, adult	10204-103F6	318.58	19.39	24.56	0.00	1.29	6.46
vein, adult	10191-103E2	331.65	34.85	37.26	0.00	0.00	9.43
xeroderma pigentosum b cell line:XPL 17	10563-108A5	54.74	22.43	17.36	0.00	0.00	6.68